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PROTEIN SYNTHESIS IN SLOWED AGING:  INSIGHTS INTO SHARED 




The following dissertation describes a series of experiments with the overall aim to 
understand the role that changes in protein synthesis have in slowed aging.  The specific aims 
of the three sets of experiments were 1) to determine if chronic administration of the mTORC1 
inhibitor rapamycin to mice increases proteostatic mechanisms in skeletal muscle, heart, and 
liver; 2) to determine if an underdeveloped anterior pituitary, caused by deletion of the Pit-1 
gene in mice, increases proteostatic mechanisms in skeletal muscle, heart, and liver of long-
lived Snell dwarf mice; 3) and to determine if transient nutrient restriction during the suckling 
period in mice (i.e. crowded litter), increases proteostatic mechanisms in skeletal muscle, heart, 
and liver later in life.  In Experiment #1 we found that mitochondrial proteins were preferentially 
synthesized in skeletal muscle and that global protein synthesis in the heart was maintained 
despite reduced cellular proliferation and mTORC1 activity in mice fed rapamycin compared to 
normal diet controls.  Originally we determined that these data were indicative of an improved 
somatic maintenance of skeletal muscle mitochondria and the heart proteome.  Since we could 
not account for changes to other energetic processes (e.g. metabolism), we reasoned that our 
data was more consistent with proteostasis, a component of somatic maintenance.  In 
Experiment #2 we developed a novel method for assessing proteostasis and determined that 
Snell dwarf mice had an increase in proteostatic mechanisms across sub-cellular fractions 
within skeletal muscle and heart compared control mice, despite differential rates of protein 
synthesis in the face of decreased mTORC1.  Together with our previous investigations into 
rapamycin fed and caloric restriction models of long-life we concluded that increased 





Experiment #3 we demonstrate that the crowded litter mouse transitions from growth to 
maintenance as it ages.  Furthermore, in the crowded litter mouse, we demonstrate that 
proteostasis is not dependent upon decreased mTORC1.  Our results indicate that decreased 
mTORC1 does not necessarily correlate to decreases in protein synthesis across all sub-cellular 
fractions.  Discerning which proteins and the mechanism(s) of how specific proteins can be 
preferentially synthesized despite decreases in protein synthesis in other fractions and 
decreased mTORC1, may give further insight into characteristics of slowed aging.  Further, we 
demonstrate that increases in proteostasic mechanisms are a shared characteristic of multiple 
unique models of slowed aging and therefore, provides a basis for future work aimed at slowing 
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The accumulation of damaged proteins over time, particularly of mitochondrial proteins, 
has been postulated to propagate the development of the aging phenotype (1-4).  Age-
dependent reductions in protein turnover are estimated to range from 20-80% (5), resulting in 
damaged proteins making up 20-50% of the total protein pool (1).  In tissues that have limited 
proliferative potential, such as skeletal muscle, heart, and liver, protein homeostasis (i.e. 
proteostasis) is a key component of slowed, or healthy aging (4, 6-10).  Therefore, interventions 
that promote proteostasic mechanisms could be an effective means to slow the aging process.         
The overall objective of our projects was to understand how changes in protein synthesis 
contribute to slowed aging.  Previous work in our lab had shown that life-long caloric restriction 
in mice, a potent and reproducible means to extend lifespan, did not change mitochondrial 
biogenesis, contrary to what had been suggested by others (11).  Further, we showed that 
protein synthesis in other (non-mitochondrial) sub-cellular fractions was maintained during 
caloric restriction despite decreased cellular proliferation and mTORC1 activity (11, 12).  The 
mTORC1-signaling pathway is a central regulator of protein turnover and cell cycling (13), and 
its inhibition is a characteristic of several models of slowed aging.  Under the premise that 
decreased protein turnover is causative to the aging phenotype, our findings in the caloric 
restriction model were unexpected. A reduction in cellular proliferation suggests that energy 
normally devoted to cell cycling is conserved.  This conserved energy may provide for the 
preferential synthesis of key proteins (e.g. mitochondrial proteins) during the energetic stress of 
caloric restriction despite decreased mTORC1, promoting slowed aging.   
 To expand upon our findings in the caloric restriction model, we began our studies in 
mice treated with rapamycin, an mTORC1 inhibitor and potential caloric restriction mimetic that 





maintenance required the assumption that energetic contributions from other cellular processes 
(e.g. metabolism) remained unchanged (15, 16).  Since we did not account for energetic 
changes in other processes within caloric restriction and rapamycin models we thought it 
prudent to limit further discussion to processes our data better reflected.  Through further 
reflection and experimental insight we reasoned that our data were consistent with proteostasis 
(6). 
Intracellular enzymatic capacity for protein repair is low so damaged proteins must be 
degraded then replaced through the making of new proteins (17-19). Growth requires protein 
synthesis to increase alongside cellular proliferation (20, 21) or recruitment of new DNA from 
neighboring satellite cells (22-25). Cells constantly integrate intra- and extracellular signals to 
coordinate the synthesis of new proteins in order to adapt to the current stressor/stimuli 
environment.  In contrast to growth, cellular adaptation to the current environment is not 
necessarily dependent upon cell proliferation.  Taken together, protein synthesis both equips 
newly made cells as well as regulates cellular proteostasis.  Therefore, cellular proliferation 
must be accounted for along with protein synthesis in order to determine if newly made proteins 
are dedicated to making new cells or maintaining existing cellular structures. As a result of this 
new interpretation of our data, the terminology used in the subsequent manuscripts reflects this 
evolution in our thought process.  
Using proteostasis as the new framework for interpreting our findings, we next 
investigated the longest-lived mouse model of slowed aging, the Snell dwarf mouse (26).  
Mutation of the Pit-1 locus in Snell dwarf mice causes underdeveloped anterior pituitary glands, 
resulting in pronounced life-long reductions in hormonal growth factors (e.g. such as growth 
hormone and insulin-like growth factor-1) and mTORC1 (27, 28).  Life-long reductions in growth 
factors and related signaling differ from caloric restriction and rapamycin models where 





Finally, we investigated a presumed epigenetic model of long-life, the crowded litter 
mouse, that is characterized as having an increase in lifespan due to being nutrient restricted 
during the suckling period alone (29). The crowded litter model allows for comparisons of how a 
transient stress changes protein synthesis later in life compared to our other models where 
slowed aging is imparted through chronic interventions.  We expand upon our previous findings 
in other models by also assessing crowded litter mice before they become weight stable, 
allowing insight into changes associated with potential restricted or catch-up growth.    
In summary, the series of studies presented here began as an investigation into the role 
that changes in protein synthesis, particularly of mitochondrial proteins, have in slowed aging.  
In the end we arrived at the idea that increased proteostatic mechanisms are a shared 
characteristic of long-lived models. We characterize proteostasis in a pharmacological model 
(rapamycin) of long-life, and propose that preferential synthesis of key proteins, such as 
mitochondrial proteins, may be causative to slowed aging.  Further, in a genetic model of long-
life (Snell dwarf) we develop novel means to analyze our data that we believe is indicative of 
proteostasis and show that proteostatic mechanisms are increased across sub-cellular fractions.  
Lastly, we assess proteostasis in a presumed epigenetic model of long-life (crowded litter) and 
show that a transient intervention that increases lifespan also increases proteostatic 
mechanisms later in life, and we propose that proteostasis is not dependent on mTORC1 
inhibition.  
 
Overall Hypothesis:  Proteostatic mechanisms will be increased in tissues of varying mitotic 
capacity across pharmacological, genetic, and presumed epigenetic models of long-life.   
 
Specific Aim for Experiment 1:  To determine if chronic administration of the mTORC1 inhibitor 






Specific Aim for Experiment 2:  To determine if an underdeveloped anterior pituitary, due to 
deletion of the Pit-1 gene in mice, increases proteostatic mechanisms in skeletal muscle, heart, 
and liver of long-lived Snell dwarf mice.   
 
Specific Aim for Experiment 3:  To determine if transient nutrient restriction during the suckling 

































Assessment of mitochondrial biogenesis and mTORC1 signaling during 





Chronic inhibition of the protein synthesis regulator mTORC1 through rapamycin 
extends lifespan in mice, with longer extension in females than in males.  Whether rapamycin 
treatment inhibits protein synthesis or if it does so differently between sexes has not been 
examined. UM-HET3 mice were fed a control (CON) or rapamycin-supplemented (Rap) diet for 
12 weeks. Protein synthesis in mixed, cytosolic (cyto), and mitochondrial (mito) fractions, as well 
as DNA synthesis and mTORC1-signaling were determined in skeletal muscle, heart, and liver.  
In both sexes, mito protein synthesis was maintained in skeletal muscle from Rap despite 
decreases in mixed and cyto fractions, DNA synthesis, and rpS6 phosphorylation.  In the heart, 
no change in protein synthesis occurred, despite decreased DNA synthesis.  In heart and liver, 
Rap males were more sensitive to mTORC1 inhibition than Rap females.  In conclusion, we 
show changes in protein synthesis and mTORC1 signaling that differ by sex and tissue. 
Introduction 
 
The protein turnover theory of aging states that aging is the result of accumulated 
protein damage resulting from decreased protein turnover (2). In aging, damaged proteins are 
estimated to make up 20-50% of the total protein pool (1) and this accumulation in damaged 
proteins is accompanied by a 20-80% decrease in protein turnover (5).  In particular, damage to 
mitochondrial proteins increases with age [reviewed in (30)], and one experiment suggests that 
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the synthesis of mitochondrial proteins in skeletal muscle decreases by middle age in humans 
(3). Thus, interventions that prevent age-related changes in protein stability and turnover could 
be used to slow aging. 
We have recently demonstrated in mice that life-long caloric restriction (CR), a well 
documented means of lifespan extension in a variety of species, maintains the synthesis of 
mitochondrial proteins (a true measure of mitochondrial biogenesis (31)) in skeletal muscle, 
heart, and liver (11).  In addition, DNA synthesis (indicative of cellular proliferation) decreased in 
heart and liver across ages (11).  The simultaneous maintenance of mitochondrial biogenesis 
with a decrease in cellular proliferation, both energetically expensive processes, during limited 
energy availability (i.e. CR) suggests an increase in somatic maintenance.  Thus, somatic 
maintenance of mitochondria could be a part of how the lifespan extension effect of CR is 
mediated.  Although our long-term studies demonstrated maintained synthesis of mitochondrial 
proteins in heart and skeletal muscle during CR (11), subsequent acute (4hrs) labeling 
measurements of life-long CR mice show that synthesis rates were decreased in liver with CR 
(12).   These additional findings highlight the importance of examining tissue specificity when 
assessing potential aging outcomes.   
Protein synthesis is modulated, in part, by the highly conserved mechanistic 
(mammalian) target of rapamycin (mTOR) signaling pathway [reviewed in (32)].  The mTOR 
kinase is a protein that forms two distinct complexes, mTORC1 and mTORC2, with mTORC1 
being essential for protein synthesis (33).  mTORC1 is a potent cellular nutrient sensor and 
initiates the synthesis of new proteins only in the presence of adequate nutrients (34).  
mTORC1 is also involved in the regulation of cell cycling, as evident by the upregulation of 
mTORC1 in many cancers [reviewed in (13)].  Therefore, mTORC1 signaling is a nexus of 
control for both protein synthesis and cell cycling.  
Inhibition of mTORC1 increases lifespan in a variety of non-mammalian species (35-37).  





and maximal lifespan in genetically heterogeneous mice (14), with a greater effect in females 
compared to males (14, 38), however it remains unknown what factors may be contributing to 
lifespan extension.  Rapamycin acts through binding to its intracellular protein target, the FK506 
binding protein 1A (FKBP12) (39).  This drug-receptor complex destabilizes the raptor-mTOR 
interaction in the rapamycin sensitive mTORC1 (40), inhibiting its kinase activity leading to 
reduced protein synthesis (41, 42) and suppressed cellular proliferation at the G1 phase of the 
cell cycle (43).  Though rapamycin is expected to decrease protein synthesis because of its 
inhibition of mTORC1, this has only been demonstrated in vitro (41, 42).  Furthermore mTORC1 
signaling varies between sexes (44), making it possible that male and female mice exhibit 
varying responses to mTOR inhibition through rapamycin and thus variable protein and DNA 
synthesis outcomes.  Therefore, assessing sex-specific changes in protein and DNA synthesis 
may help to explain why the lifespan extension effect of chronic rapamycin feeding is more 
pronounced in females compared to males. 
Given the rapamycins’s well-characterized inhibition of mTOR signaling by rapamycin, it 
is imperative that chronic effects are analyzed to determine how these essential processes 
governed by mTOR are altered so as to gain insight into how rapamycin extends lifespan.  In 
principle, reduced protein synthesis and cellular proliferation with rapamycin treatment could 
each contribute to the drug’s lifespan extension effects.  A decrease in global protein synthesis 
and cellular proliferation with chronic rapamycin feeding could lead to significant energy savings 
that could be allocated to somatic maintenance of key proteins, including mitochondrial proteins, 
thus increasing lifespan.  It is yet to be determined if mitochondrial biogenesis is maintained in 
mice chronically fed rapamycin as observed during CR (11).  
The goal of the current study was to measure tissue-specific protein and DNA synthesis 
simultaneously during chronic rapamycin feeding to determine what tissue(s) and/or fractions 
are preferentially maintained. We hypothesized that during chronic rapamycin feeding, 





and that DNA synthesis would decrease.  We further hypothesized that protein and DNA 
synthesis responses to rapamycin feeding will differ between tissues and sexes.  Understanding 
how chronic rapamycin treatment affects tissue specific protein synthesis, mitochondrial 
biogenesis, and cellular proliferation in a variety of tissues and in both sexes, could lead to 
potential treatments targeting somatic maintenance of mitochondrial proteins to promote slowed 
aging. 
Materials and Methods 
 
Animals 
All procedures and conditions at the animal care facility meet or exceed the standards 
for animal housing as described in the Animal Welfare Act regulations, the Guide for the Care 
and Use of Laboratory Animals and the Guide for the Care and Use of Agricultural Animals in 
Agricultural Research and Teaching and were approved by the University of Michigan 
Committee on Use and Care of Animals.  We used the genetically heterogeneous offspring of 
CB6F1 female and C3D2F1 male mice (UM-HET3), which have been well characterized in their 
response to chronic rapamycin feeding (14).    
Routine veterinary care was provided by the Biomedical Science Research Center, 
Animal Research Core staff at the University of Michigan. UM-HET3 mice were fed chow mixed 
with rapamycin (n=12) at 14 mg/kg food (equivalent to 2.24 mg of rapamycin/kg body 
weight/day) or normal chow (n=12) in accordance with the original study describing lifespan 
extension (14). Diets were administered beginning at 4 mo of age.  After 8 wks on the control 
(CON) or rapamycin (Rap) diet mice received 2H2O for 4 wks.  After the labeling period and 
following an overnight fast, mice were anesthetized using a CO2 overdose according to the 
AVMA Guidelines on Euthanasia.  Complete loss of pedal reflexes was confirmed before tissues 





plantaris), mixed skeletal muscle], heart, liver, bone marrow from the tibia, and blood via cardiac 
puncture were taken and immediately frozen in liquid nitrogen for later analysis.   
 
Labeled water 
The use of 2H2O (heavy water) allows simultaneous assessment of multiple synthetic 
processes.  Here, we assessed the synthesis of mitochondrial (mito), cytosolic (cyto), and mixed 
(mixed) protein and DNA in skeletal muscle, heart, and liver according to procedures previously 
described (11, 12, 45, 46).  After 8 wks of the dietary intervention the animals received an 
intraperitoneal injection of 99% enriched 2H2O calculated to enrich the body water pool 
(assumed 60% of body weight) to 8% (11, 46).  Animals were then allowed to drink ad libitum 
water enriched to 4% for the next 4 wks. 
 
Tissue isolation - Tissue from skeletal muscle, heart and liver was fractionated according to our 
previously published procedures (11, 12, 47). Tissue (25-60 mg) was homogenized 1:10 in 
isolation buffer (100 mM KCl, 40 mM Tris HCl, 10 mM Tris Base, 5 mM MgCl2, 1 mM EDTA, 1 
mM ATP, pH=7.5) with phosphatase and protease inhibitors (HALT, Thermo Scientific, 
Rockford, IL, USA) using a bead homogenizer (Next Advance Inc, Averill Park, NY, USA).  After 
homogenization, the samples were centrifuged at 800 g for 10 min at 4 °C (Eppendorf, model 
5415R, Hauppauge, NY, USA).  The resulting pellet (mixed fraction, Mix) was washed in EtOH 
and H2O .  The supernatant from the 800 g spin was centrifuged at 9000 g for 10 min.  400 µl of 
the resulting supernatant was used as our cytosolic fraction (Cyto) and the remainder was set 
aside for Western blotting.  The pellet from the 9000 g spin was resuspended in a second 
isolation buffer (100 mM KCl, 10 mM Tris HCl, 10 mM Tris Base, 1 mM MgCl2, 0.1 mM EDTA, 
0.02 mM ATP, and 1.5% BSA, pH = 7.5) and centrifuged at 8000 g for 10 min at 4 °C.  The 





for 10 min at 4 °C.  The supernatant was discarded and the remaining mitochondrial pellet was 
washed with H2O.  The supernatant from the 9000 g spin (Cyto) was mixed with 400 µl 14% 
sulfosalicyclic acid, vortexed, and centrifuged at 16,000 g for 10 min.  The resulting supernatant 
was discarded and the pellet washed in EtOH and H2O.  Finally, 250 µl 1 M NaOH was added to 
all fraction pellets then placed on heat block at 50 °C and 900 rpm for 15 min. 
 
Preparation of analytes for mass spectrometric analyses - Protein was hydrolyzed by incubation 
in 6 N HCl at 120 °C for 24 hrs.  The hydrolysates were ion-exchanged, dried under vacuum, 
and then suspended in 1 mL molecular biology grade H2O.  Approximately 500 µl of suspended 
samples were then derivitized by adding 500 µl acetonitrile, 50 µl 1 M K2HPO4 (pH = 11), and 20 
µl of pentafluorobenzyl bromide (Pierce Scientific, Rockford, IL, USA), and the sealed mixture 
was incubated at 100 °C for 1 hr.  Derivatives were extracted into ethyl acetate and the organic 
layer was removed and dried by N2 followed by vacuum centrifugation.  Samples were 
reconstituted in 1 ml ethyl acetate then analyzed. 
 For the plasma body water concentration analysis 125 µl of plasma was placed into the 
inner well of o-ring screw on cap and placed inverted on a heating block overnight at 80 °C.  
Next, 2 µl of 10 M NaOH and 20 µl of acetone was added to all samples and 20 µl 0-20% D2O 
standards and capped immediately.  Samples were vortexed at low speed and sat overnight at 
room temperature.  Samples were extracted with addition of 200 µl hexane and the organic 
layer transferred through anhydrous Na2SO4 into Gas Chromotography (GC) vials and analyzed 
via Electron Ionization (EI) mode using a DB-17MS column (Agilent Technologies Inc, Santa 
Clara, CA, USA). 
 
GC-MS analysis of derivatized amino acids - Using negative chemical ionization (NCI), 





MS using an Agilent DB-5MS gas chromatograph column (30 m x 0.25 mm x 0.25 micron).  
Samples were injected in 1 µl volumes using splitless mode (inlet temp 220°C).  Helium was the 
carrier and methane was the reagent gas.  The mass-to-charge ratios of 448, 449, and 450 
were monitored for the pentafluorobenzyl-N,N-di(pentafluorobenzyl)alaninate derivative.  In all 
cases, these mass-to-charge ratios represented the primary daughter ions that included all of 
the original hydrocarbon bonds from the given amino acid.  2H enrichment was calculated as 
described previously (48).  The newly synthesized fraction (f) of muscle proteins was calculated 
from the true precursor enrichment (p) using plasma analyzed for 2H2O enrichment then 
adjusted using MIDA (45).  Protein synthesis was calculated as the change in enrichment of 
deuterium-labeled alanine (45) bound in muscle proteins over the entire labeling period and 
expressed as fraction new in 4 weeks. 
 
DNA isolation - Total DNA (~8 µg) was extracted from approximately 15 mg tissue (QiAamp 
DNA mini kit Qiagen, Valencia, CA, USA).  The deoxyadenosine fraction was separated and 
analyzed for deuterium content by GC-MS as previously described (11, 45, 49).  DNA from bone 
marrow was isolated by extracting ~300 mg from the bone marrow suspension.  Bone marrow 
suspension was centrifuged for 10 min at 2000 g.  The pellet was treated the same as the tissue 
DNA isolation. 
 
DNA synthesis measurement - Determination of 2H incorporation into purine deoxyribose (dR) of 
DNA was performed as described previously (11, 45, 49).  Briefly, isolated DNA was hydrolyzed 
overnight at 37 °C with nuclease S1 and potato acid phosphatase.  Hydrolysates were reacted 
with pentafluorobenzyl hydroxylamine and acetic acid and then acetylated with acetic anhydride 
and 1-methylimidazole.  Dichloromethane extracts were dried, resuspended in ethyl acetate, 
and analyzed by GC/MS on a DB-17 column with NCI, using helium as carrier and methane as 





and 436 (M1) of the pentafluorobenzyl triacetyl derivative of purine dR were quantified using 
ChemStation software.  Excess fractional M+1 enrichment (EM1) was calculated as: 
 
EM1=    (abundance m/z 436)sample      -        (abundance m/z 436)std    
 (abundance m/z 435. 436)sample      (abundance m/z 4345. 436)std 
 
where sample and standard (std) refer to the analyzed sample and unenriched 
pentafluorobenzyl triacetyl purine dR derivative standard, respectively.  The fractional new in 4 
weeks was calculated by a comparison with bone marrow in the same animal, which represents 
an essentially fully turned over population of cells. 
 
Western blotting 
A portion of the Cyto fraction was used for western blot analysis.  Protein concentration 
was determined using a bicinchoninic acid assay (Thermo Fisher, Rockford, IL, USA).  Samples 
were diluted to the same concentration, boiled with Laemmli buffer, then 20 µg of protein was 
separated using 10 % SDS-PAGE at 125 V.  Proteins were transferred at 4 °C (100 V for 75 min 
in 20 % w/v methanol, 0.02 % w/v SDS, 25 mM Tris Base, 192 mM glycine, pH=8.3) to 
nitrocellulose paper and incubated in 5 % Milk in Tris-buffered saline with Tween20 (TBST) for 1 
hr.  Antibodies were purchased from Cell Signaling Technologies (Boston, MA, USA; rpS6 
phospho-Ser[240/244] #4858, rpS6 total #2217, 4E-BP1 phospho [Thr37/46] #9459, 4E-BP1 
total #9452) or Santa Cruz Biotechnology (Santa Cruz, CA, USA; Actin #sc-1616).  Blots were 
incubated overnight with primary antibodies diluted 1:1000, 1:2000 (Liver rpS6), or 1:250 
(Actin).  Blots were washed in TBST and incubated with anti-rabbit or anti-goat (Actin) HRP-
conjugated secondary antibody diluted 1:5000 in 5 % Milk with subsequent chemiluminescence 
detection (West Dura; Pierce, Rockford, IL, USA).  Images were captured and densitometry 





phosphorylated proteins first, placed in stripping buffer (GM Biosciences, Rockville, MD, USA) 
for 5min, and then re-probed for total protein.  Equal loading was verified using Ponceau-s 
staining as well as with actin. Due to undetectable rpS6 in skeletal muscle homogenate, a 
portion of the homogenate used for western blotting was acetone precipitated.    
 
Statistics 
Statistical analysis was performed using SAS (SAS Institute Inc, Cary, NC, USA) for 
data in Fig 1A & 2A and SPSS Statistics 20 (IBM Corporation, Armonk, NY, USA) for all 
subsequent data analysis. Data were assessed by two-way ANOVA. For pooled protein 
synthesis data in Fig 1A & 2A significant interaction effects were further analyzed via pairwise 
comparisons and least squares means estimate. Where applicable data were transformed to 
equalize variance.  Significance was set at p ≤ 0.05, and p values of < 0.10 are noted.  Outliers 
were determined as values outside 2x standard deviation of the mean and were removed from 




In skeletal muscle the main effects of fraction and treatment were significant (p=0.048 
and p<0.0001, respectively) (Fig 1.1A).  The interaction effect between fraction and treatment 
for skeletal muscle was p=0.1 (Fig. 1.1A), which we deemed worthy of further investigation via 
pair-wise comparisons.  Pair-wise comparisons showed that Rap mixed and cyto fractions were 
significantly decreased compared to mixed and cyto from CON (p=0.035 and p=0.017, 
respectively), but that mito Rap was not significantly different compared to mito CON (p=0.315) 
(Fig. 1.1A).  The least squares means estimate showed that the Rap vs. CON difference in 
mixed and cyto was significantly different (p=0.004 and p=0.048, respectively), however, the 





chronic rapamycin feeding in skeletal muscle did not vary between sexes in any protein fraction 
(Fig. 1.1B-D).  P-values are summarized in Table S1.1. 
In heart, protein synthesis in Rap mice did not differ from CON in any fraction (Fig. 
1.2A).  There was no interaction effect between treatment and sex or a main effect of treatment 
between sexes in the heart (Fig. 1.2B-D).  A significant sex effect was observed in the heart; 
females had significantly less mixed and mito protein synthesis compared to males (Fig. 1.2B & 
D).  P-values are summarized in Table S1.2.   
Protein turnover in the liver was complete after 4 weeks of deuterium labeling, making 
assessment of differences in CON and Rap not possible (data not shown).   
 
DNA Synthesis 
In skeletal muscle DNA synthesis was significantly decreased in Rap compared to CON 
independent of sex (Fig 1.3A).  Of note, a trend towards a significant interaction effect for 
rapamycin and sex was observed (p=0.083) (Fig. 1.3A).  DNA synthesis in heart was also 
significantly decreased in Rap compared to CON (Fig. 1.3B).  There was significantly less DNA 
synthesis in the hearts of females compared to males (Fig. 1.3B).  In the liver, a significant 
interaction effect was found for Rap and sex (Fig. 1.3C): DNA synthesis was decreased in Rap, 
but the effect was only observed for the males.  Main effect means of the two-way ANOVA for 
DNA synthesis are found in Table S1.3.   
 
mTORC1 signaling  
The ratio of phosphorylated Ser235/236 rpS6 to total rpS6 (P:T) was significantly lower 
in skeletal muscle of Rap compared to CON independent of sex (Fig. 1.4A).  Heart and liver 
displayed a significant interaction effect, between sex and treatment, for rpS6 (P:T) (Fig. 1.4B & 
C).  For each of these two tissues, rpS6 phosphorylation in CON males was higher than seen in 





assessment of phosphorylated and total rpS6 alongside their respective actin loading control is 
found in Fig S1.1. There was no difference in the ratio of phosphorylated Thr37/46 to total 4E-
BP1 between Rap and CON in skeletal muscle, though a trend towards an effect of sex was 
observed (p=0.067; males higher than females) (Fig 1.5A).  A significant interaction effect 
between sex and treatment was found for heart 4E-BP1: Rap had diminished 4E-BP1 (P:T)  in 
heart tissue but only in the females (Fig. 1.5B).  Furthermore, female mice had more 4E-BP1 
than males (Fig 1.5B).  For liver, no difference was found in 4E-BP1 (P:T) between Rap and 
CON, though females had significantly more 4E-BP1 (P:T) compared to males (Fig. 1.5C). Main 
effect means of the two-way ANOVA for rpS6 (P:T) and 4E-BP1 (P:T) are found in Table S1.4 
and S1.5, respectively.  Individual assessment of phosphorylated and total 4E-BP1 alongside 
their respective actin loading control is found in Fig. S1.2. 
 
Discussion 
Here we present a tissue and sex-specific assessment of protein synthesis in mixed, 
cyto, and mito fractions, along with DNA synthesis following 12 weeks of rapamycin feeding in 
mice.  In skeletal muscle, chronic rapamycin feeding slows DNA synthesis and protein synthesis 
in mixed and cyto fractions but has no effect on mitochondrial protein synthesis (biogenesis).  
DNA synthesis was also inhibited in the heart but without any alteration in protein synthesis in 
any fraction.  No sex differences were observed in response to chronic rapamycin feeding within 
skeletal muscle and heart.  However, mTORC1-related signaling was differentially affected by 
chronic rapamycin feeding between sex and tissue.    Collectively, we present evidence that 
sub-fraction and tissue-dependent maintenance of protein synthesis despite decreased cellular 
proliferation and mTORC1 signaling could be a distinguishing sex and tissue-dependent 







Potential mechanism for rapamycin mediated lifespan extension  
Chronic administration of rapamycin extends median and maximum lifespan in mice (14, 
38) as well as maximal lifespan in Drosophila melanogaster (50) and yeast (35).  In mice, 
chronic rapamycin feeding slows age-associated tissue degeneration (51), attenuates 
inflammation and stabilizes atherosclerotic plaques (52), protects against cognitive decline, and 
increases behaviors indicative of reduced anxiety-like symptoms (53).  Therefore, chronic 
administration of rapamycin not only increases lifespan but also healthspan through pathways 
still to be elucidated in each of the affected tissues and cell types. 
How chronic administration of rapamycin affects protein synthesis and cellular 
proliferation in various tissue types has not previously been explored in intact mice or other 
mammals.  We have previously shown that life-long CR results in maintained mitochondrial 
biogenesis despite decreases in cellular proliferation and mTORC1-signaling in skeletal muscle, 
heart, and liver (11).  A reduction in mTORC1 regulated global protein synthesis and cellular 
proliferation through rapamycin could result in a re-allocation of energetic resources.  We 
hypothesized that this available energy could then be diverted towards somatic maintenance of 
mitochondrial proteins thus promoting longevity.   
 In the current study, 12 weeks of rapamycin feeding maintained mitochondrial protein 
synthesis, a true measure of mitochondrial biogenesis (31), in both skeletal muscle and heart of 
male and female mice, mirroring our previous study in life-long CR mice (11).  Protein synthesis 
in the liver is not reported because the faster rate of protein turnover in the liver resulted in 
100% new protein in our 4-week period.  Therefore, we hypothesize that the maintenance of 
mitochondrial biogenesis is a common factor in long-lived models and should be evaluated 
further using additional tissues of varying mitotic capacity and models of longevity. 
 The maintenance of mitochondrial biogenesis with chronic rapamycin feeding should be 
considered in the context of the cell types contained in various tissues.  Tissues that have 





sensitive to accumulation in damaged proteins, potentially contributing to dysfunction and 
organismal senescence [reviewed in (54)].  In the current study, Rap had significantly reduced 
DNA synthesis in skeletal muscle and heart compared to CON; a similar change was seen in 
liver of male, but not female, animals.  A decrease in cellular proliferation could suggest that 
DNA mutations are limited.  Furthermore, other means may be needed to deal with an 
accumulation in damaged proteins over time.   Autophagy, which is negatively regulated my 
mTOR (55) and recycles damaged organelles and proteins, may be increased with chronic 
rapamycin treatment within these tissues.   
The similar decrease in the skeletal muscle and heart DNA synthesis is contrasted by 
decreased Mix and Cyto protein synthesis in skeletal muscle but no change in heart protein 
synthesis.  These data suggests an energetic savings which in Rap mice may be directed 
toward somatic maintenance of the existing mitochondrial reticulum in skeletal muscle and the 
heart proteome.  Thus the somatic maintenance of key proteins/tissues may be integral to 
chronic rapamycin-induced longevity. 
 
Sexual dimorphism of lifespan extension 
Rapamycin mediated lifespan extension is greater in females than males (14).  Sexual 
dimorphic lifespan extension occurs in other long-lived models (26, 56, 57) but the reason(s) as 
to why is unclear.  It could be that the mechanism through which longevity is increased in these 
models differs between sexes.  Here, we show that chronic rapamycin decreased skeletal 
muscle protein synthesis in both male and female mice. Furthermore, in both sexes, rapamycin 
decreased DNA synthesis in both heart and skeletal muscle.  In contrast, liver DNA synthesis 
was decreased only in males, suggesting that cellular proliferation in the liver of female mice is 
unaffected by rapamycin.  Therefore, it is important to consider both sexes when assessing 





 Differences in mTORC1-related signaling between sexes could contribute to the greater 
extension in lifespan from rapamycin treatment in females.  In rats, rpS6 is decreased in female 
EDL compared to males but rpS6 and 4E-BP1 is increased by 36mo of age (44).  However, 
there is no sex difference in soleus 4E-BP1 (44).  Therefore, we hypothesized that chronic 
rapamycin feeding may have sex and tissue-specific effects on mTORC1 signaling in mice.  
Phosphorylation of rpS6 in skeletal muscle was decreased in Rap compared to CON in both 
sexes.  In heart and liver, however, rapamycin feeding diminished rpS6 phosphorylation only in 
males, a novel finding.  Levels of phosphorylated rpS6 were higher in control males than in 
control females, consistent with data in rat EDL muscle (44).  The rapamycin effect in males 
thus diminished rpS6 phosphorylation to the low levels already present in the control females.  
Chronic rapamycin feeding had quite different effects on 4E-BP1 phosphorylation.  In skeletal 
muscle, unlike rpS6, there was no change in 4E-BP1 phosphorylation, which was also observed 
in the liver.  Furthermore, a decrease in 4E-BP1 phosphorylation was seen only in the heart of 
female Rap.  To our knowledge, this is the first in vivo report of sex and tissue-specific 
difference in the phosphorylation of rpS6 (heart and liver) and 4E-BP1 (heart) to chronic 
rapamycin feeding.  Also, though rapamycin resistance has been reported for 4E-BP1 in vitro 
during long exposures (58, 59), this is the first report of in vivo rapamycin resistant 4E-BP1 
phosphorylation varying by sex in the heart.   
Furthermore, sex and tissue differences in one facet of mTORC1 signaling suggests the 
possibility that chronic rapamycin feeding alters other aspects of mTOR signaling (e.g. 
autophagy) in a sex and tissue specific manner as well.  Therefore, additional investigations of 
the effects of chronic rapamycin on other mTOR regulated processes in relation to lifespan are 
warranted. 
Cap-dependent translation of mRNA is dependent on the formation of the eIF4F initiation 
complex, which is regulated by mTORC1 by relieving 4E-BP1 inhibition of cap-dependent 





suggests the novel finding that mRNA within these two tissues are cap-dependently translated 
during chronic rapamycin feeding.  It is difficult to assess what maintenance of 4E-BP1 (P:T) in 
the liver means in the current study due to the lack of liver protein synthesis data.  However, we 
have recently demonstrated that short term CR results in decreased mitochondrial biogenesis 
within the liver (12).  Thus, skeletal muscle and liver may preferentially synthesize different 
mRNAs via cap-dependent means during chronic suppression of mTORC1. 
 
Perspective and conclusion 
Inhibiting mTORC1 signaling via rapamycin is a robust and reproducible means of 
extending lifespan in a variety of species.  Despite the well-known effects of rapamycin on 
inhibiting mTOR signaling, the effect on protein synthesis and cellular proliferation in various 
cellular compartments in vivo have not previously been described.  Here, we demonstrate that 
in both male and female mice, chronic rapamycin feeding maintains mitochondrial biogenesis in 
skeletal muscle and global protein synthesis in the heart despite decreasing DNA synthesis in 
both tissues.  Also, we demonstrate sex and tissue-specific differences exist in mTORC1 
signaling as measured by phosphorylated rpS6 and 4E-BP1.  Further investigation into how key 
proteins are preferentially translated in models of presumed mTOR-mediated longevity (e.g. 
dietary rapamycin & CR) may give additional insight into age-related sex and tissue 
dimorphisms.     Also, these data are consistent with the idea of somatic maintenance as 
necessary for lifespan extension and that the mechanism of somatic maintenance may differ by 
sex and tissue.  Therefore, we recommend that future studies that investigate long-lived models 
do so using multiple tissues and both sexes to draw conclusions. 
 
Addendum to manuscript I 
Since the publication of this manuscript, our interpretation of these data in the rapamycin 





through the comparison of the rate of new proteins synthesized to the rate of cellular 
proliferation.  These retrospective analyses, along with an expanded rationale, can be found in 
Fig 4.1 and Appendix II. 
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Figure 1.1.  Skeletal muscle protein synthesis over 4 weeks in Rap and CON.  Mixed and cyto 
fraction protein synthesis were decreased but mito protein synthesis was maintained in Rap 
mice compared to CON (A).  Mixed protein synthesis was decreased in Rap compared to CON 
regardless of sex (B).  Cyto protein synthesis was decreased in Rap compared to CON 
regardless of sex (C).  Mito protein synthesis was maintained in Rap compared to CON 






Figure 1.2.  Heart protein synthesis over 4 weeks in Rap and CON.  No difference was found in 
any fraction between Rap and CON (A).   Females had less mixed protein synthesis than males 
(B).  No sex difference in Rap and CON in cyto fraction (C).   Females had less mito protein 














Figure 1.3.  Cellular proliferation as measured by DNA synthesis over 4 weeks in Rap and CON.  In skeletal muscle, Rap DNA 
synthesis was significantly decreased compared to CON (A).  In heart, Rap DNA synthesis was significantly decreased compared to 
CON and females had significantly decreased DNA synthesis than males (B).  In liver, a significant interaction effect between 
rapamycin and sex was observed (C). n = 11-12 per pooled group, n = 5-6 per sex/group.  * = p<0.05 for Rap vs. CON; # = p<0.05 








Figure 1.4.  Western blotting of mTORC1 substrate rpS6.  In skeletal muscle rpS6 phosphorylated to total protein (P:T) decreased in 
Rap compared to CON (A).   A significant interaction effect for rapamycin and sex was observed in the heart and liver (B & C).  n = 








Figure 1.5.  Western blotting of mTORC1 substrate 4E-BP1.  Skeletal muscle 4E-BP1 phosphorylated to total protein (P:T) was not 
changed in Rap compared to CON (A).  A significant interaction effect between rapamycin and sex was found in the heart (B).  In the 
liver no change was observed in Rap compared to CON but females had significantly more 4E-BP1 (P:T) than males. n = 12 per 
pooled group, n = 6 per sex/group.  Representative blots shown.  * = p<0.05 for Rap vs. CON; # = p<0.05 for pooled sex difference; ^ 






Table S1.1.  Two-Way ANOVA summary for Fig 1.  
 
Protein Synthesis  
Skeletal Muscle  
    p-value 
Fig 1A  Fraction <0.001 
  Treatment 0.048 
  Interaction 0.100 
      
Fig 1B - Mix Treatment 0.019 
  Sex 0.748 
  Interaction 0.682 
      
Fig 1C - Cyto Treatment 0.017 
  Sex 0.173 
  Interaction 0.465 
      
Fig 1D - Mito Treatment 0.327 
  Sex 0.635 







Table S1.2.  Two-Way ANOVA summary for Fig 2.   
 
Protein Synthesis  
Heart   
    p-value 
Fig 2A  Fraction <0.001 
  Treatment 0.226 
  Interaction 0.810 
      
Fig 2B - Mix Treatment 0.831 
  Sex 0.008 
  Interaction 0.307 
      
Fig 2C - Cyto Treatment 0.524 
  Sex 0.056 
  Interaction 0.816 
      
Fig 2D - Mito Treatment 0.117 
  Sex 0.004 













Table S1.4.  Main effect means of rpS6 two-way ANOVA.  All data shown has been log 







Table S1.5.  Main effect means of 4E-BP1 two-way ANOVA.  Skeletal muscle data was cube 








Figure S1.1.  Western blotting of phospho (Ser235/236) rpS6 and total rpS6.  Skeletal muscle 
rpS6 and respective actin loading control A-C.  Skeletal muscle p-rpS6 data was rank 
transformed and total rpS6 was log transformed to equalize variance.    Heart rpS6 and 
respective actin loading control D-F.  Heart p-rpS6 data was log transformed to equalize 
variance.  Liver rpS6 and respective actin loading control G-I.  Liver p-rpS6 data was log 
transformed to equalize variance.  n = 11-12 per pooled group, n = 5-6 per sex/group.  
Representative blots shown.  * = p<0.05 for Rap vs. CON. # = p<0.05 for pooled sex difference; 






Figure S1.2.  Western blotting of phospho (Thr36/47) and total 4E-BP1.  Skeletal muscle 4E-
BP1 and respective actin loading control A-C. Heart 4E-BP1 and respective actin loading control 
D-F.  Liver 4E-BP1 and respective actin loading control G-I.  n = 12 per pooled group,  n = 6 per 

















Proteostasis is a key factor thought to contribute to slowed aging.  We have shown 
evidence of increased proteostatic mechanisms across several models of long-life, suggesting 
that proteostasis may be a shared characteristic of slowed aging.  The Snell dwarf mouse 
(Snell) has an underdeveloped anterior pituitary due to a mutation in the Pit-1 locus.  The Snell 
model has pronounced lifelong reductions in multiple hormonal growth factors and mTORC1 as 
well as the largest lifespan extension of long-lived rodent models.  We hypothesized that 
proteostatic mechanisms would be increased in Snell compared to control (Con).  We assessed 
protein synthesis in mixed (Mix), cytosolic (Cyto), and mitochondrial (Mito) fractions 
simultaneously with DNA synthesis via D2O labeling as well as mTORC1 signaling in skeletal 
muscle, heart, and liver over two weeks in both sexes.  Protein synthesis in Snell mice was 
decreased in all fractions assessed in skeletal muscle compared to Con.  In the heart, protein 
synthesis in Snell was decreased in Cyto but increased in Mix and Mito fractions compared to 
Con.  No differences in protein synthesis were found between Snell and Con in the liver.  DNA 
synthesis in Snell was lower in skeletal muscle and heart but not liver compared to Con.  The 
protein to DNA ratio, indicative of proteostasis, was increased 3-fold in Snell skeletal muscle 
and heart.  Snell rpS6 was decreased in heart and liver compared to Con.  No effect of sex was 
seen in this study.  Together with our previous investigations in long-lived models, these data 








Protein turnover decreases with age, resulting in a progressive accumulation of 
damaged proteins and propagation of the aging phenotype (1, 2). Maintaining protein 
homeostasis (i.e. proteostasis) through coordination of mRNA translation, protein synthesis, 
folding, and compartmental targeting is a key component of slowed, or healthy aging (4, 10).  
Therefore, interventions that promote proteostatic mechanisms could be effective in the 
promotion of slowed aging. 
Enzymatic capacity for protein repair is low, meaning damaged proteins must be 
removed (e.g. autophagy, etc) and replaced by the synthesis of new proteins (17-19).  
Therefore the synthesis of new proteins is essential to cellular proteostasis (10).  Though 
protein synthesis is a critical component of proteostasis, assessment of protein synthesis alone 
may not give sufficient insight into proteostasis.  For example, in proliferative tissues, cell 
division requires an increase in protein synthesis to ensure equality between daughter cells 
(20).  Similarly, in post-mitotic tissues such as skeletal muscle, hypertrophy requires an increase 
in protein synthesis along with the recruitment of DNA from resident stem cells so as to maintain 
the myonuclear domain (61).   Adaptation to the intra- and extracellular environment in various 
cell types requires increases in protein synthesis to maintain cellular homeostasis, which are not 
necessarily dependent upon cell proliferation.  Therefore assessing proteostasis in both 
proliferative and post-mitotic tissues should include measurements of both protein synthesis and 
DNA synthesis (i.e. cellular proliferation).  
The mTOR-signaling pathway integrates nutrient and hormonal signaling to regulate 
protein turnover (e.g. protein synthesis, cell cycle, and autophagy) via two multi-protein 
complexes, mTORC1 and mTORC2 (13).  Life-long caloric restriction (CR) and chronic 
administration of rapamycin (Rap) both inhibit mTORC1 and increase lifespan in a sexually 
dimorphic manner (14, 62).  Using deuterium oxide (D2O) in both long-lived CR and Rap 





mTORC1 signaling (11, 12, 63).  Therefore, decreased mTORC1 signaling may be necessary 
for proteostasis in models of long-life.  
 The Snell dwarf mouse model has a mutation of the Pit-1 locus that results in an 
underdeveloped anterior pituitary, causing reductions in anterior pituitary hormone production 
(e.g. growth hormone) and reduced mTORC1 signaling (27, 28).   Compared to their respective 
controls, the Snell dwarf mouse has the greatest increase in lifespan among rodent models of 
slowed aging (56).  Though female Snell dwarfs significantly outlive their male counterparts, 
both sexes of Snell mice have a much longer lifespan extension compared to Rap and CR 
models (14, 62).  The pronounced reduction in mTORC1 signaling and hormonal growth factors 
throughout the lifespan in Snell, in contrast to CR and Rap interventions that begin later in life, 
make the Snell model ideal for expanding the concept of increased proteostatic mechanisms as 
a key mediator of slowed aging.  Therefore, we hypothesized that proteostatic mechanisms, as 
assessed by DNA and protein synthesis, would be increased in Snell compared to controls 
(Con) and would correspond with decreased mTORC1-related signaling.  We also assessed 
these parameters by sex to determine if proteostasis is reflective of the sexual dimorphic 
lifespan extension in Snell. 
Materials and Methods 
 
Animals 
All procedures and conditions at the animal care facility meet or exceed the standards 
for animal housing as described in the Animal Welfare Act regulations and the Guide for the 
Care and Use of Laboratory Animals.  All procedures were approved by the University 
Committee on Use and Care of Animals at the University of Michigan.  Routine veterinary care 
was provided by the Biomedical Science Research Building staff.  Snell dwarf and control mice 
were produced by crossing C3H/HeJ-PitdwJ/+ females with DW/J-Pit1dw/= males producing (DW/J 





littermate controls using both dw/+ and +/+mice as indistinguishable controls.  After weaning 
(21-23 days), mice were housed in single-sex groups of 3-4 mice per cage (64).  Animals were 
kept on a 12-hour light and dark cycle and fed ad libitum. 
At 7 months of age (age-matched to our previous investigations in long-lived models (11, 
12, 63, 89), Snell dwarf and control mice (n=5 per sex, n=10 per group) received deuterium 
oxide (D2O) for two weeks.  After the labeling period and following an overnight fast, mice were 
euthanized using a CO2 overdose according to the AVMA Guidelines on Euthanasia.  Complete 
loss of pedal reflexes was confirmed before tissues were collected.  The posterior aspect of the 
distal hind limbs (gastroc complex - gastrocnemius, soleus, and plantaris [i.e. mixed skeletal 
muscle]), heart, liver, bone marrow from the tibia, and plasma via blood from cardiac puncture 
were taken and immediately frozen in liquid nitrogen for later analysis. 
 
Deuterium Oxide 
We assessed protein synthesis in mitochondrial enriched (Mito), cytosolic (Cyto - other 
cytosolic organelles with the exception of mitochondria and nucleus), and mixed (Mix; nuclei, 
plasma membranes, and contractile proteins [heart and skeletal muscles]) subcellular fractions 
from skeletal muscle heart and liver (11, 12, 45, 46, 63, 89).  Also, we assessed DNA synthesis 
according to procedures previously described (11, 12, 45, 46, 63, 89).  Animals received an 
intraperitoneal injection of 99% enriched D2O to enrich the body water pool (assumed 60% of 
body weight) to 5% (11, 46, 89).  Animals then received 8% D2O in their drinking water with ad 
libitum access for 2 weeks. 
 
Protein Synthesis Measurement 
Protein isolation - Tissues were fractionated according to our previously published procedures 
(11, 12, 47, 63, 89). Tissues (15-50 mg) were homogenized 1:10 in isolation buffer (100 mM 





phosphatase and protease inhibitors (HALT, Thermo Scientific, Rockford, IL, USA) using a bead 
homogenizer (Next Advance Inc, Averill Park, NY, USA).  After homogenization, sub-cellular 
fractions were isolated via differential centrifugation as previously described (11, 12, 63, 89).  
Once fraction pellets were isolated and purified, 250 µl 1 M NaOH was added and pellets were 
incubated for 15 min at 50 °C and 900 rpm. 
 
Preparation of analytes for mass spectrometric analyses - Protein was hydrolyzed by incubation 
for 24 hrs at 120 °C in 6 N HCl.  The hydrolysates were ion-exchanged, dried under vacuum, 
and resuspended in 1 mL molecular biology grade H2O.  500 µl of suspended samples were 
derivatized (500 µl acetonitrile, 50 µl 1 M K2HPO4 (pH = 11), and 20 µl of pentafluorobenzyl 
bromide (Pierce Scientific, Rockford, IL, USA)), sealed, and incubated at 100 °C for 1 hr.  
Derivatives were extracted into ethyl acetate.  The organic layer was removed and dried by N2 
followed by vacuum centrifugation.  Samples were reconstituted in 1 ml ethyl acetate then 
analyzed. 
 To determine body water enrichment, 125 µl of plasma was placed into the inner well of 
o-ring screw cap and inverted on heating block overnight.  2 µl of 10 M NaOH and 20 µl of 
acetone was added to all samples and to 20 µl 0-20% D2O standards then capped immediately.  
Samples were vortexed at low speed and left at room temperature overnight.  Extraction was 
performed by the addition of 200 µl hexane.  The organic layer was transferred through 
anhydrous Na2SO4 into GC vials and analyzed via EI mode using a DB-17MS column. 
 
GC-MS analysis of derivatized amino acids – The pentafluorobenzyl-N,N-di(pentafluorobenzyl) 
derivative of analnine was analyzed on an Agilent 7890A GC coupled to an Agilent 5975C MS 
as previously described (11, 12, 49, 63, 89). The newly synthesized fraction (f) of proteins was 





and adjusted using mass isotopomer distribution analysis (MIDA) (45).  Protein synthesis was 
calculated as the ratio of deuterium-labeled to unlabeled alanine (45) bound in proteins over the 
entire labeling period and expressed as fraction new in 2 weeks. 
 
DNA synthesis measurement  
DNA isolation – Approximately 100 ng/ul (heart, gastroc complex) and 500ng/ul (liver) of total 
DNA was extracted from ~20 mg tissue (QiAamp DNA mini kit Qiagen, Valencia, CA, USA).  
DNA from bone marrow was isolated by extracting ~300 mg from the tibial bone marrow 
suspension and centrifuged for 10 min at 2000 g. 
 
Preparation of analytes and GC-MS analysis of derivatized purine deoxyribose - Isolated DNA 
was hydrolyzed overnight at 37 °C with nuclease S1 and potato acid phosphatase.  
Hydrolysates were reacted with pentafluorobenzyl hydroxylamine and acetic acid and then 
acetylated with acetic anhydride and 1-methylimidazole.  Dichloromethane extracts were dried, 
resuspended in ethyl acetate, and analyzed by GC/MS as previously described (11, 45, 49, 63, 
89).  The fraction of new DNA in 2 weeks was calculated by comparison with bone marrow 
(representing an essentially fully turned over cell population and thus the precursor enrichment) 
in the same animal (11, 63).  From the synthesis rates of protein and DNA, we calculated the 
protein synthesis to DNA synthesis ratio to be indicative of proteostasis.  This ratio illustrates 
how much new protein is made in relation to the rate of cellular proliferation (new DNA) during 
the labeling period.  
 
Western blotting 
Western blots were completed on a portion of the Cyto fraction.  Protein concentration 
was determined using a bicinchoninic acid assay (Thermo Fisher, Rockford, IL, USA).  Samples 





was separated using 10 % SDS-PAGE at 100 V.  Proteins were transferred at 4 °C (100 V for 
75 min in 20 % w/v methanol, 0.02 % w/v SDS, 25 mM Tris Base, 192 mM glycine, pH=8.3) to 
nitrocellulose and incubated in 5 % nonfat dry milk in Tris-buffered saline with Tween20 (TBST) 
for 1 hr.  Antibodies were purchased from Cell Signaling Technologies (Boston, MA, USA; rpS6 
phospho-Ser[235/236] #4858, rpS6 total #2217, 4E-BP1 phospho [Thr37/46] #9459, 4E-BP1 
total #9452) or Santa Cruz Biotechnology (Santa Cruz, CA, USA; (β-tubulin #sc-5274).  Blots 
were incubated overnight with primary antibodies diluted 1:500 (skeletal muscle rpS6), 1:1000, 
1:2000 (Liver rpS6), or 1:500 (β-tubulin).  Blots were washed in 1x TBST and incubated with 
anti-rabbit or anti-mouse (β-tubulin) HRP-conjugated secondary antibody diluted 1:5000 in 5% 
milk with subsequent chemiluminescence detection (West Dura; Pierce, Rockford, IL, USA).  
Images were captured and densitometry analyzed by UVP Bioimaging system (Upland, CA, 
USA).  Blots were probed for phosphorylated proteins first, placed in stripping buffer (GM 
Biosciences, Rockville, MD, USA) and then re-probed for total protein.  Equal loading was 
verified using ponceau-s staining and β-tubulin. Due to undetectable rpS6 in skeletal muscle 
and some heart samples, a portion of the homogenate was acetone precipitated to concentrate 
proteins then analyzed via western blotting.    
 
Statistics 
Statistical analysis was performed using Prism V4.0c (GraphPad Software, Inc. La Jolla, 
CA, USA).  Protein synthesis data grouped by subcellular fraction and all sex comparisons were 
assessed by two-way ANOVA.  Combined sexes DNA synthesis data was assessed via two-
sided Student’s t-test.  Significance was set at p < 0.05, and p-values of ≤ 0.10 are noted.  Data 








Protein and DNA Synthesis 
In skeletal muscle, Snell dwarf mice had significantly lower rates of protein synthesis in 
all fractions compared to Con (Fig 2.1A).  In the Mix fraction there was a significant interaction 
between condition (Snell versus Con) and sex (Fig 2.1B).  There were no sex differences in 
protein synthesis in Cyto or Mito fractions (Fig 2.1C, D).  Independent of condition, males had 
significantly greater rates of protein synthesis in Cyto compared to females (Fig 2.11C).   
In heart, there was a significant interaction between condition (Snell versus Con) and 
tissue fraction, with greater rates of proteins synthesis in Mix and Mito fractions and lower rates 
of Cyto protein synthesis in Snell dwarfs compared to Con (Fig 2.2A).  However, when 
separated by sex, there was not a significant condition effect in Mix or Cyto  (Fig 2.2B, C).  In 
both female and male Snells, Mito protein synthesis was increased compared to their respective 
Con (Fig 2.2D).  Independent of condition, males had significantly greater rates of protein 
synthesis in the Mix and Mito fraction compared to females (Fig 2.2B, D).  
In liver, Snell had a trend (p=0.067) for lower protein synthesis in all sub-cellular 
fractions assessed compared to Con (Fig 2.3A).  When separated by sex a trend (p=0.060) for 
Snell dwarfs having lower protein synthesis was found only in Mix (Fig 2.3B).  Independent of 
condition, male protein synthesis was significantly increased compared to females in Cyto and 
trended towards an increase in Mix (p = 0.06) and Mito (p = 0.076)  (Fig 2.3B, C, D). 
DNA synthesis rates were significantly less in Snell compared to Con in both heart and 
skeletal muscle, but were not different from Con in liver (Fig 2.4A).  Decreased DNA synthesis 
in Snell compared to Con was also present when the data were separated by sex (Fig 2.4B, C, 
D).  
In both skeletal muscle and heart, there was a significant increase in the protein to DNA 





(Fig 2.5B, D).  In the liver, there was no difference in the protein to DNA synthesis ratio between 
Snell and Con or when separated by sex (Fig 2.5E, F). 
 
mTORC1 signaling 
Phosphorylation of the mTORC1 substrate, ribosomal protein S6 (rpS6), was 
significantly decreased in heart and liver, as well as in both sexes of Snell compared to Con (Fig 
2.6B, C).  Even with acetone precipation we were unable to assess a visible band for rpS6 in 
skeletal muscle.  Phosphorylation of another mTORC1 substrate, eukaryotic initiation factor 4E 
binding protein 1 (4E-BP1), was not statistically different in any tissue or between sexes (Fig 2.6 
D, E, F), though a slight interaction trend between condition (Snell) and sex was observed in 
skeletal muscle (p=0.098) (Fig 2.6 D, E). 
Discussion 
 
Here we present a tissue and sex-specific assessment of proteostasis via DNA and 
protein synthesis in long-lived Snell dwarf mice.  We tested the hypothesis that Snell mice would 
exhibit increased proteostatic mechanisms across multiple tissues; consistent with our findings 
in other slowed aging models (11, 12, 63, 89).   Also, we investigated if proteostatic 
mechanisms would be more pronounced in female compared to male Snell mice given their 
female-biased sexual dimorphic lifespan.  We demonstrate that proteostatic mechanisms, as 
assessed by protein to DNA synthesis ratio, is indeed increased by 3-fold in skeletal muscle and 
heart, but independent of sex, in Snell compared to Con.  Additionally, the mTORC1-substrate, 
rpS6, was decreased in heart and liver. Collectively, our data further suggest proteostasis is a 
shared characteristic of slowed aging but cannot explain the sex difference in Snell lifespan (11, 







Proteostasis in Snell dwarf mice. 
 Proteostasis involves the coordinated control between concentration, location, and 
conformation of proteins within cells (6) and has recently become a key outcome in 
understanding the aging process (6-9).  Protein synthesis, along with protein folding, trafficking, 
and degradation, is an important process capable of regulating proteostasis (6).  Since the 
intrinsic capacity of cells to enzymatically repair proteins is low (17, 18), damaged proteins must 
instead be removed (e.g. proteosome, autophagy, etc.) and replaced through the synthesis of 
new proteins (19).  Therefore protein synthesis has an essential role in maintaining cellular 
stability and repair, and thus proteostasis (10). 
 Proliferative cells must double in mass through increased protein synthesis in order to 
ensure equality between daughter cells (21).  In post-mitotic cells (e.g. skeletal muscle), 
increases in protein synthesis are accompanied by recruitment of new DNA from resident stem 
cells in order to maintain the myonuclear domain (23-25).  Proteostasis requires constant 
integration of multiple intra- and extracellular signals in order to coordinate the synthesis of new 
proteins to adapt to the current environment, which is not necessarily dependent on cellular 
proliferation. Therefore, protein synthesis should be assessed in parallel with cellular 
proliferation in order to determine if new proteins are dedicated to cell doubling or maintenance 
of existing cellular structures.     
 In the current study, we used D2O to simultaneously assess both protein and DNA 
synthesis across multiple tissues and between sexes (11, 12, 45, 46, 49, 63) in the long-lived 
Snell dwarf mouse.  We show the novel finding that protein synthesis is decreased in all 
subcellular fractions, including mitochondria, in skeletal muscle.  A decrease in mitochondrial 
protein synthesis (i.e. mitochondrial biogenesis (31)) is counter to the idea of slowed aging (3).  
However, when decreased mitochondrial, as well as Mix and Cyto, protein synthesis rate is 
considered in relation to the decreased rate of DNA synthesis in skeletal muscle, the ratio of 





To us, this suggests that new proteins are synthesized in existing cells, thus maintaining 
existing cellular structures, including mitochondria, (i.e. proteostasis) in Snell dwarf skeletal 
muscle.  In the heart, protein synthesis in Mix and Mito fraction is increased, whereas Cyto 
protein synthesis is decreased in Snell compared to Con.  Again, the new protein to new DNA 
synthesis ratio shows a 3-fold increase in proteostatic mechanisms across sub-cellular fractions 
in Snell heart despite the differential protein synthesis response between fractions compared to 
Con. Our findings of increased proteostatic mechanisms in Snell mice are in accordance with 
long-lived CR and Rap mouse models of the same age (11, 12, 63), thus suggesting that 
proteostasis is a shared characteristic of long-lived models. 
An increase in proteostatic mehcanisms within Snell heart and skeletal muscle is 
contrasted by the lack of statistical significant differences in the liver between Snell and Con.  
Liver has a much higher protein turnover rate than skeletal muscle and heart (11, 12, 63, 89), 
thus making it challenging to capture synthesis rates in liver protein while still allowing for 
sufficient incorporation of deuterium into DNA across tissues.  In the current study, one liver 
sample in Con was fully turned over, while others were >98% new.  Combined with the 
significant decrease in rpS6 phosphorylation in Snell liver, we therefore suspect that a true 
difference in liver protein synthesis between Snell and Con is present that we were unable to 
capture because of our extended labeling period.  Thus, a shorter labeling period may give 
further insights into proteostasis within Snell liver. 
 
mTORC1-related signaling 
 The mTORC1 signaling pathway is thought to be a key regulator of proteostasis due to 
its control over protein turnover and cell cycling (13).  Furthermore, decreased mTORC1 
signaling is a common characteristic of long-lived models (11, 14, 28, 63, 65).  We found that 
rpS6 phosphorylation was decreased in heart and liver from Snell mice compared to Con but 





differences in 4E-BP1 phosphorylation within any tissue.  The translation of mRNA, which is 
subject to mTORC1 control, is prone to errors in amino acid incorporation at a rate of 1 in every 
103 to 104 codons mistranslated (66),  and may increase with age creating more abhorrent 
polypeptides (4).  Rapamycin induced decreases in rpS6 phosphorylation in vitro has been 
shown to regulate proteostasis through slowing the rate of elongation, thus increasing the 
fidelity of translated polypeptides (67).  However, as we have demonstrated here and elsewhere 
(11, 63), decreased rpS6 phosphorylation in vivo does not always correlate to decreased protein 
synthesis across sub-cellular fractions or tissues.  Taken together, our findings in Snell suggest 
that increased proteostatic mechanisms is not necessarily dependent on decreased mTORC1 
(89), but rather on the investment of new proteins towards repair rather than growth.  How 
proteins are differentially synthesized despite decreased mTORC1 is of significant interest and 
may be important in slowed aging (63).  
 
Proteostasis and sex in Snell dwarf mice 
 With the exception of protein synthesis in the Mix fraction of skeletal muscle, there were 
no sex differences in protein or DNA synthesis, or mTORC1 signaling in Snell.  Given the sexual 
dimorphic lifespan of Snell dwarf mice this was an unexpected finding.  Though an interaction 
between sex and protein synthesis was noted in the skeletal muscle mix fraction, this sex 
difference did not persist in the ratio of new proteins to new DNA synthesis.  However, the 
findings presented here do not rule out the possibility that sex-differences in synthetic outcomes 
of other tissues may contribute to sexual dimorphic lifespan or that the longer lifespan in Snell 
females may be due to other factors not directly related to proteostasis.    
 
Summary and Conclusions 
Manipulating gene targets (e.g. Pit1 in Snell dwarf mice) can have multiple downstream 





synthetic rates provide excellent insight into complex models such as the Snell dwarf.  By 
comparing the amount of new protein to the rate of cell proliferation, we illustrate that 
proteostatic mechanims are uniformly increased across sub-cellular fractions in Snell skeletal 
muscle and heart even though rates of protein synthesis were different between fraction and 
tissue.  How proteins are differentially synthesized despite decreased mTORC1 may be 
important in slowed aging but further suggests that proteostasis may not be dependent on 
decreased mTORC1.  Collectively, we provide novel evidence using kinetic measurements that 








Figure 2.1.  Protein synthesis in skeletal muscle and between sexes over 2 weeks in Snell and 
Con.  Protein synthesis was significantly decreased in Snell compared to Con in Mix, Cyto, and 
Mito fraction (A).  In Mix there was a significant interaction between condition (Snell) and sex 
(B).  Protein synthesis was decreased in both female and male Snell compared to their 
respective Con in Cyto and Mito (C, D).  Independent of condition, Cyto protein synthesis was 
increased in males compared to females (C).  n = 5 per sex, n = 10 per group.  * = p<0.05 for 
Snell vs CON; # = p<0.05 difference between sexes independent of condition; ^ = p<0.05 






Figure 2.2.  Protein synthesis in heart and between sexes over 2 weeks in Snell and Con.  
There was a significant interaction in protein synthesis between condition (Snell) and fraction 
(A).  Mix protein synthesis was significantly increased in pooled males compared to pooled 
females (B).  A trend (p=0.064) of decreased protein synthesis was observed for both sexes in 
Cyto (C).  Mito protein synthesis was increased in both sexes (C).  Males independent of 
condition had increased protein synthesis compared to females (C). n = 5 per sex, n = 10 per 
group.  * = p<0.05 for Snell vs Con; # = p<0.05 difference between sexes independent of 






Figure 2.3.  Protein synthesis in liver and between sexes over 2 weeks in Snell and Con.  A 
trend (p=0.067) of decreased protein synthesis was observed across fractions in Snell 
compared to Con and protein synthesis was significantly different between fractions (A).  A 
trend (p=0.060) for decreasing protein synthesis in both sexes within mix was observed; also 
mix protein synthesis was significantly higher in males compared to females, independent of 
condition (B).  Males had higher Cyto protein synthesis compared to females, independent of 
condition (C).  In Mito there was a trend (p=0.076) for increased protein synthesis in males 
compared to females independent of condition (D).  n = 5 per sex, n = 10 per group, except for 
Con Cyto n = 9 corresponding to n = 4 in male Con Cyto.  * = p<0.05 for Snell vs Con; † = 







Figure 2.4.  DNA synthesis in skeletal muscle, heart, and liver and between sexes over 2 weeks 
in Snell and Con.  DNA synthesis was significantly decreased in skeletal muscle and heart but 
no change was observed in liver DNA synthesis between Snell compared to Con (A).  When 
separated by sex, the decrease in DNA synthesis in Snell compared to Con was conserved in 
females and males in skeletal muscle and heart (B, C).  No sex differences in DNA synthesis 






Figure 2.5.  Protein to DNA synthesis ratios in skeletal muscle, heart, and liver and between 
sexes in Snell and Con.  In skeletal muscle and heart there was a significant increase in the 
protein to DNA ratio in mix, cyto, and mito fractions (A, B), which was conserved in both sexes 
(C, D).  No change in the protein to DNA ratio between Snell and Con was observed in liver or 






Figure 2.6.  Western blotting of mTORC1 substrates rpS6 and 4E-BP1 in skeletal muscle, 
heart, and liver of Snell and CON.  rpS6 phosphorylation was significantly decreased in heart 
and liver, which was conserved in both sexes (A, B).  We were unable to detect rpS6 in skeletal 
muscle.  An interaction trend in skeletal muscle (p=0.098) 4E-BP1 between condition (Snell) 
and sex was observed (C).  No changes in 4E-BP1 were found in heart or liver between Snell 

























Increasing litter size in mice, termed crowded litter (CL), imposes a transient energetic 
stress during suckling but increases lifespan through unknown mechanism(s).  We have 
previously shown protein and DNA synthesis changes (indicative of proteostasis) alongside 
mTOR inhibition, in long-lived caloric restriction and rapamycin models.  Therefore, we 
hypothesized that proteostasis may be a shared characteristic of other long-lived models, 
including CL mice.  We assessed protein and DNA synthesis, and mTORC1 signaling in skeletal 
muscle, heart, and liver of 4 and 7 month (mo) CL mice.  At 4 mo, DNA synthesis was greater in 
gastrocnemius complex of CL compared to control (CON) with no differences in protein 
synthesis in any tissue between groups.  By 7 mo, CL had less DNA synthesis in heart and 
greater protein synthesis, including mitochondrial, in heart, liver, and skeletal muscle compared 
to CON.  Furthermore, in 7 mo CL, phosphorylation of rpS6 and 4E-BP1 was increased 
compared to CON.  These data suggest that between 4 and 7 mo in CL, new proteins are 
directed towards proteostasis rather than new cells, independent of mTORC1 inhibition.  
Together with our previous investigations, these data in CL mice support the notion that 
proteostasis is a shared characteristic of long-lived models.   
Introduction 
 
A progressive age-dependent reduction in protein turnover results in an accumulation of 
damaged proteins and propagates the development of the aging phenotype (1, 2).  In tissues 





functional proteins (i.e. proteostasis) has become a key outcome in aging research as a means 
to maintain homeostatic function with age (6, 7).  Thus, interventions that maintain protein 
stability could lead to slowed aging.   
In proliferative tissues, growth is accomplished by cell replication, which requires the 
duplication of DNA and of cellular machinery through increased protein synthesis [reviewed in 
(20)].  In non-proliferative tissues (e.g. skeletal muscle) growth is accomplished by increased 
protein synthesis, which may be followed by recruitment of satellite cell nuclei to maintain a 
constant cytoplasmic to nuclear ratio (22).  Since there is low enzymatic capacity for protein 
repair within cells, damaged proteins must be removed and subsequently replaced through 
synthesis (17, 18).  Therefore, in addition to protein folding, trafficking, and degradation, the 
making of new protein is a primary means by which to regulate proteostasis (6).  In order to gain 
insight into proteostasis the simultaneous assessment of DNA synthesis (i.e. cellular 
proliferation) along with protein synthesis gives context to how new proteins are used; either for 
new cells/growth or maintaining existing cellular structures.   
The mechanistic (formerly mammalian) target of rapamycin (mTOR) signaling pathway 
promotes growth by increasing protein synthesis and cellular cycling via two multi-protein 
complexes, mTORC1 and 2 [reviewed in (13)].  Caloric restriction (CR) (68, 69) and chronic 
rapamycin administration (14, 51, 70) suppress mTORC1 activity and increase lifespan and 
healthspan in various species.  Our lab has shown that in lifelong CR (11, 12) and chronically 
rapamycin treated mice (63), mTORC1 activity is reduced, DNA synthesis is decreased (i.e. 
decreased growth), but mitochondrial biogenesis and global protein synthesis are maintained.  
Therefore in CR mice and mice exposed to rapamycin, the maintenance of protein synthetic 
rates, despite lower levels of DNA synthesis and mTORC1 signaling, suggests that protein 
synthesis is directed toward the maintenance of existing cellular structures rather than growth 






The nutritional environment of the developing fetus can have a profound impact on gene 
expression throughout the lifespan of the offspring, affecting healthspan and longevity (71-73).  
Furthermore, it has been demonstrated that changing litter size or post-natal maternal protein 
intake can change offspring lifespan, suggesting that some degree of genomic plasticity also 
remains during the postnatal suckling period (29, 73-76).  For example, increasing litter size by 
50% for the first 3 weeks of life, a model termed crowded litter (CL), extends mean and maximal 
lifespan (29).  The increase in litter size presumably imposes a transient caloric restriction 
period until the pups are weaned and given free access to food (29).  How a transient energetic 
stress at such a young age extends lifespan is unknown.  Therefore, we hypothesized that in CL 
mice there would be an increase in proteostatic mechanisms that is consistent with other long-
lived models in that protein synthesis in the liver, heart, and skeletal muscle would be 
maintained despite decreased DNA synthesis and mTORC1 signaling. 
Materials and Methods  
 
Animals 
All procedures and conditions at the animal care facility meet or exceed the standards 
for animal housing as described in the Animal Welfare Act regulations, the Guide for the Care 
and Use of Laboratory Animals, and were approved by the University Committee on Use and 
Care of Animals at the University of Michigan.  We used the genetically heterogeneous offspring 
of CB6F1 female and C3D2F1 male mice (UM-HET3), which have been well characterized for 
the development of the CL model (29, 75). 
Routine veterinary care was provided by the Biomedical Science Research Building 
staff.  UM-HET3 litters were culled to 8 and an additional 4 mice from separate litters were 
added, resulting in a 50% increase in litter size (29).  Control (CON) UM-HET3 mice were 
maintained in a litter size of 8 pups.  After the 3-week suckling period, female mice were 





mice/group/cage) with ad libitum access to food and water.  At 4 months (mo) (not weight 
stable, still growing) and 7 mo of age (weight stabilizing, and same age as our previous 
investigations in long-lived models) (11, 29, 63), CL (n=4, per age group) and CON (n=4, per 
age group) mice received deuterium labeled water (D2O) for two weeks.  After the labeling 
period and following an overnight fast (7 mo only), mice were euthanized using a CO2 overdose 
according to the AVMA Guidelines on Euthanasia.  Complete loss of pedal reflexes was 
confirmed before tissues were collected.  The posterior aspect of the distal hind limbs (gastroc 
complex - gastrocnemius, soleus, and plantaris [i.e. mixed skeletal muscle]), tibialias anterior 
(TA, 7 mo animals only, predominately Type II fibers), heart, liver, bone marrow from the tibia, 
and plasma via blood from cardiac puncture were taken and immediately frozen in liquid 
nitrogen for later analysis. 
The 4 mo mice were not fasted the night before sacrifice.  Therefore, in order to assess 
mTORC1 signaling at a younger age, an additional cohort of approximately 3 mo CL and CON 
(n=4, respectively) were sacrificed following an overnight fast and gastroc complex and liver 
were harvested as already reported.   
 
Labeled water 
We assessed protein synthesis in mitochondrial enriched (Mito), cytosolic (Cyto), and 
mixed (Mix; nuclei, plasma membranes, and contractile proteins [heart and skeletal muscles]) 
subcellular fractions, and whole tissue DNA synthesis in skeletal muscle, heart, and liver 
according to procedures previously described (11, 12, 45, 46, 63).  Animals received an 
intraperitoneal injection of 99% enriched D2O to enrich the body water pool (assumed 60% of 
body weight) to 8% (11, 46).  Animals were then received 8% D2O in their drinking water with ad 






Tissue isolation - Tissue were fractionated according to our previously published procedures 
(11, 12, 47, 63). Tissues (25-60 mg) were homogenized 1:10 in isolation buffer (100 mM KCl, 40 
mM Tris HCl, 10 mM Tris Base, 5 mM MgCl2, 1 mM EDTA, 1 mM ATP, pH=7.5) with 
phosphatase and protease inhibitors (HALT, Thermo Scientific, Rockford, IL, USA) using a bead 
homogenizer (Next Advance Inc, Averill Park, NY, USA).  After homogenization, sub-cellular 
fractions were isolated via differential centrifugation as previously described (11, 12, 63).  Once 
fraction pellets were isolated and purified, 250 µl 1 M NaOH was added and pellets were 
incubated for 15 min at 50 °C and 900 rpm. 
 
Preparation of analytes for mass spectrometric analyses - Protein was hydrolyzed by incubation 
for 24 hrs at 120 °C in 6 N HCl.  The hydrolysates were ion-exchanged, dried under vacuum, 
and resuspended in 1 mL molecular biology grade H2O.  500 µl of suspended samples were 
derivatized (500 µl acetonitrile, 50 µl 1 M K2HPO4 (pH = 11), and 20 µl of pentafluorobenzyl 
bromide (Pierce Scientific, Rockford, IL, USA)), sealed, and incubated at 100 °C for 1 hr.  
Derivatives were extracted into ethyl acetate.  The organic layer was removed and dried by N2 
followed by vacuum centrifugation.  Samples were reconstituted in 1 ml ethyl acetate then 
analyzed. 
 To determine body water enrichment, 125 µl of plasma was placed into the inner well of 
o-ring screw on cap and placed inverted on heating block overnight.  2 µl of 10 M NaOH and 20 
µl of acetone was added to all samples and to 20 µl 0-20% D2O standards and capped 
immediately.  Samples were vortexed at low speed and left at room temperature overnight.  
Extraction was performed by the addition of 200 µl hexane.  The organic layer was transferred 






GC-MS analysis of derivatized amino acids – The pentafluorobenzyl-N,N-di(pentafluorobenzyl) 
derivative of analnine was analyzed on an Agilent 7890A GC coupled to an Agilent 5975C MS 
as previously described (11, 12, 49, 63). The newly synthesized fraction (f) of proteins was 
calculated from the true precursor enrichment (p) using plasma analyzed for D2O enrichment 
and adjusted using mass isotopomer distribution analysis (MIDA) (45).  Protein synthesis was 
calculated as the ratio of deuterium-labeled to unlabeled alanine (45) bound in proteins over the 
entire labeling period and expressed as fraction new in 2 weeks. 
 
DNA isolation – Approximately 75 ng/ul (heart, gastroc complex, and TA) and 400ng/ul (liver) of 
total DNA was extracted from ~15 mg tissue (QiAamp DNA mini kit Qiagen, Valencia, CA, 
USA).  DNA from bone marrow was isolated by extracting ~300 mg from the tibial bone marrow 
suspension and centrifuged for 10 min at 2000 g. 
 
DNA synthesis measurement - Determination of 2H incorporation into purine deoxyribose (dR) of 
DNA from whole tissue and bone marrow was performed as described previously (11, 45, 49, 
63).  Briefly, isolated DNA was hydrolyzed overnight at 37 °C with nuclease S1 and potato acid 
phosphatase.  Hydrolysates were reacted with pentafluorobenzyl hydroxylamine and acetic acid 
and then acetylated with acetic anhydride and 1-methylimidazole.  Dichloromethane extracts 
were dried, resuspended in ethyl acetate, and analyzed by GC/MS as previously described (11, 
49, 63).  The fraction new in 2 weeks was calculated by comparison with bone marrow 
(representing an essentially fully turned over cell population and thus the precursor enrichment) 
in the same animal (11, 12, 63). 
 
Western blotting 
A portion of the Cyto fraction from 7 mo and the additional 3 mo, fasted cohort was used 





assay (Thermo Fisher, Rockford, IL, USA).  Samples were diluted to the same concentration, 
boiled with Laemmli buffer, then 30-45 µg of protein was separated using 10 % SDS-PAGE at 
100 V.  Proteins were transferred at 4 °C (100 V for 75 min in 20 % w/v methanol, 0.02 % w/v 
SDS, 25 mM Tris Base, 192 mM glycine, pH=8.3) to nitrocellulose paper and incubated in 5 % 
nonfat dry milk in Tris-buffered saline with Tween20 (TBST) for 1 hr.  Antibodies were 
purchased from Cell Signaling Technologies (Boston, MA, USA; rpS6 phospho-Ser[235/236] 
#4858, rpS6 total #2217, 4E-BP1 phospho [Thr37/46] #9459, 4E-BP1 total #9452, phospho-p90 
RSK (S380) #12032, RSK total #9355, phospho-mTOR [S2448] #2971) or Santa Cruz 
Biotechnology (Santa Cruz, CA, USA; (β-tubulin #sc-5274).  Blots were incubated overnight with 
primary antibodies diluted 1:500 (skeletal muscle rpS6, all mTOR), 1:1000, 1:2000 (Liver rpS6), 
or 1:500 (β-tubulin and RSK).  Blots were washed in 1x TBST and incubated with anti-rabbit or 
anti-mouse (β-tubulin) HRP-conjugated secondary antibody diluted 1:5000 in 5% milk with 
subsequent chemiluminescence detection (West Dura; Pierce, Rockford, IL, USA).  Images 
were captured and densitometry analyzed by UVP Bioimaging system (Upland, CA, USA).  
Blots were probed for phosphorylated proteins first, placed in stripping buffer (GM Biosciences, 
Rockville, MD, USA) and then re-probed for total protein, except for total mTOR, which we could 
not detect and therefore S2448 mTOR was normalized to β-tubulin.  Equal loading was verified 
using ponceau-s staining and β-tubulin. Due to undetectable rpS6 in skeletal muscle 
homogenate, a portion of the homogenate was acetone precipitated then analyzed via western 
blotting.    
 
Statistics 
Statistical analysis was performed using Prism V4.0c (GraphPad Software, Inc. La Jolla, 
CA, USA). Protein synthesis data were assessed by two-way ANOVA.  DNA synthesis and 





log-transformation where necessary.  Significance was set at p < 0.05, and p values of ≤ 0.10 
are noted.  Data are presented as means ± standard error of the mean (SEM). 
Results 
 
Protein and DNA synthesis 
In the gastroc complex, heart, and liver of 4 mo CL mice, there were no differences in 
protein synthesis within the Mix, Cyto, or Mito fractions compared to 4 mo CON (Fig 3.1A, C, E).  
By 7 mo of age there was a dramatic change, in that gastroc complex, heart, and liver (Fig 3.1B, 
D, F) as well as TA (Fig S3.1A) all had significantly greater rates of protein synthesis in Mix, 
Cyto, and Mito fractions compared to 7 mo CON (Fig 3.1B, D, F).  Pooled fractions (Con and 
CL) were significantly different from each other in all tissues and ages (Fig 3.1A-F).   
 In the 4 mo CL, DNA synthesis was significantly greater in the gastroc complex 
compared to CON (Fig 3.2A).  DNA synthesis in heart trended greater in the heart of 4 mo CL 
compared to 4 mo CON, but did not reach statistical significance (p=0.070; Fig 3.2A).  Liver 
DNA synthesis in 4 mo CL was not different from 4 mo CON (Fig 3.2A).  At 7 mo, CL mice had 




 At 3 mo (additional fasted cohort), there were no differences between rpS6 and 4E-BP1 
phosphorylation between groups in either gastroc complex or liver (Fig 3.3).  At 7 mo, 
phosphorylation of ribosomal protein S6 (rpS6) was significantly increased in heart and liver (Fig 
3.4B, C).  Phosphorylation of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) was 
significantly increased in gastroc complex (Fig 3.4D) and TA (Fig S3.2B).  Though they did not 
reach statistical significance, two-sided significance values for rpS6 in TA (Fig S3.2A), and for 





mTORC1 activity (77), was not different between 7 mo CL and CON in the gastroc complex, 
heart, or liver (Fig 3.5A, B, C), or in TA (Fig S3.2C).  Phosphorylation of p90 ribosomal S6 
kinase (RSK), which phosphorylates rpS6 at T389, and 4E-BP1 at T37/46 (78, 79), was not 
different between CON and CL in heart and liver (Fig 3.6A, B).  We were unable to detect RSK 
phosphorylation in either gastroc complex or TA.   
Discussion 
 
We tested the hypothesis that CL mice would exhibit increased proteostatic 
mechanisms, in that protein synthesis would be maintained despite decreased DNA synthesis 
and mTORC1 signaling, consistent with other long-lived models.  At 4 mo of age, protein 
synthesis was not different between CL and CON, but DNA synthesis was significantly greater 
in the gastroc complex and tended to be greater in the heart of CL compared to CON.  At 7 mo 
of age, however, protein synthesis was significantly greater in all tissues and fractions while 
DNA synthesis was significantly less in the heart of CL compared to CON.  Furthermore, at 3 
mo of age, the phosphorylation of mTORC1 substrates was not different between groups in any 
tissue, while at 7 mo of age rpS6 (in heart and liver) and 4E-BP1 (in gastroc complex and TA) 
was greater in CL compared to CON.  Collectively, we demonstrate for the first time that the 
transient energetic stress of a 50% increase in litter size leads to alterations in protein and DNA 
synthesis, indicative of increased proteostatic mechanisms, in mice at 7 mo of age.  Tissue 
dependent increases in mTORC1 activity in the long-lived CL model are in contrast to the 
reduced mTORC1 activity seen in long lived caloric restricted, rapamycin-treated, and S6K1-/- 
mice (11, 14, 63, 65), and the unaltered mTORC1 activity in long-lived methionine-restricted 
mice (29).  Therefore, proteostasis in CL may be accomplished by different mechanism(s) 







Postnatal feeding and growth 
Gene expression during in utero development can be profoundly affected by maternal 
nutrition, with lifelong effects on the healthspan and longevity of offspring (71-73).  Changes in 
lifespan and healthspan through litter reduction in rats (3-4 pups/litter) [reviewed in (74)] as well 
as litter enlargement (i.e. CL) experiments in mice (29, 75) suggest that nutritional status during 
early development can have long-lasting effects.  Whereas reducing litter size increases pups’ 
caloric intake leading to a vast array of pathologies associated with poor healthspan [reviewed 
in (74)], CL is the antithesis.  CL extends mean and maximal lifespan (29) and upregulates the 
transcription of at least some phase I xenobiotic enzymes (75), which are protective against 
environmental toxins.  However, it is not known how an increase in litter size affects the 
synthetic processes that contribute to growth and increased lifespan and healthspan. 
In studies of proliferative cells, new DNA may be indicative of tissue growth through cell 
replication [reviewed in (20)].  In our studies using models of slowed aging (11, 12, 63), human 
exercise (49), and our current data in CL mice, we have repeatedly demonstrated synthesis of 
new DNA in post-mitotic cardiac and skeletal muscle tissues.  In addition, we have found that 
the rates of DNA synthesis in these tissues can change with interventions that slow aging or 
with exercise.  The use of D2O to measure DNA synthesis is reflective of S-phase synthesis and 
not DNA repair (46).  Therefore, we propose two possibilities for measurable changes in DNA 
synthesis in post-mitotic tissues: 1) there is some mitotic ability in cardiac myocytes and skeletal 
muscle myofibers that are not fully appreciated, or 2) there are other cellular sources of new 
DNA in these tissues that change based on our interventions.  For example, it appears that 
cardiomyocytes have an ability to replicate their own DNA (80, 81), or incorporate DNA from 
other neighboring cell types (e.g. satellite cells) (82, 83).  In addition, it appears that the 
regulation of cardiac DNA synthesis may vary by stage of development (84).  Importantly 
though, a potential increase in heart DNA synthesis in 4 mo CL mice is in agreement with 





indicative of growth.  Similarly, skeletal muscle is primarily made up of post-mitotic, 
multinucleated myofibers, but also contains resident proliferative satellite cells, pericytes, 
interstitial cells, and myoendothelial cells (85-87).  Previous work on exercising humans in our 
lab suggest that it is unlikely that other cell types or mitochondrial DNA synthesis contribute 
significantly to our measurement of total DNA synthesis in skeletal muscle using D2O (49).  
When myofiber size increases, there is an increase in satellite cell recruitment to stabilize the 
myonuclear domain (49, 61), which isotopic labeling has been shown to reflect (88).  Therefore, 
skeletal muscle growth is characterized by increased protein synthesis, increasing myocyte 
size, and resident satellite cell duplication with subsequent donation of DNA to maintain the 
myonuclear domain.  To summarize, we believe that changes in DNA synthesis in post-mitotic 
tissues provides novel insights into growth regulation of long-lived models and may be indicative 
of cardiomyocyte and skeletal muscle myofiber proliferation, however, the contribution of other 
sources of new DNA remains a possibility. 
 
Proteostasis within long-lived models 
 Proteostasis has become a key outcome in aging research as a means to maintain 
homeostatic function with age (6, 7).  Low enzymatic capacity for protein repair within cells 
means that damaged proteins must be removed and then replaced through synthesis of new 
proteins (17, 18).  Therefore, the making of new protein is a key mediator of proteostasis (6).  In 
our present study we found changes in DNA synthesis in post-mitotic tissues that are consistent 
with our previous investigations (11, 12, 49, 63), and that indicate there is a period of growth, or 
catch up growth, to 4 mo but evidence of increased proteostatic mechanisms by 7 mo in CL 
mice.  In light of our previous investigations in long-lived models, we posit that a reduction in 
cellular proliferation allows for newly synthesized proteins to be dedicated to proteostasis (6, 11, 
12, 63) of skeletal muscle mitochondria and the heart proteome (11, 63), contributing to 





cellular proliferation and preferential maintenance of protein synthesis may be a shared 
characteristic of long-lived models.  However, the long-lived CL mouse at 7 mo is characterized 
by increased protein synthesis in all tissues and subcellular fractions within skeletal muscle, 
heart, and liver, differing from long-lived CR and chronic rapamycin fed mouse models of the 
same age (11, 63).  We also highlight elevated rates of mitochondrial protein synthesis, 
indicative of mitochondrial biogenesis (31), which are consistent with our previous work in other 
long lived models and hypothesized to be key to slowed aging (11, 38, 63).  Increases in protein 
synthesis are necessary for growth to ensure duplication of cellular machinery upon cell division 
[reviewed in (20)].  Increased protein synthesis while DNA synthesis is decreased (heart) or 
unchanged (gastroc complex, TA, and liver) in 7 mo CL suggests increased proteostatic 
mechanisms since the increased synthesis of new proteins is not supplying an elevated rate of 
cell division.  It is important to note that the CL model is generated from mice of the same 
heterogeneous background (UM-HET3) as in our previous investigation of chronic rapamycin 
feeding (63), and thus strain differences cannot account for their differing protein and DNA 
synthetic responses.  In summary, the CL model supports the concept of increased proteostatic 
mechanisms (6, 11, 12, 63) as described in our previous studies using long-lived CR and 
chronic rapamycin models.  Further, we speculate that in CL mice, a tissue-dependent tradeoff 
from growth to proteostasis occurs between 4 mo and 7 mo of age that is characterized by 
increased protein synthetic rates in all subcellular fractions despite decreased or unchanged 
rates of DNA synthesis (11, 12, 63).   
 
CL growth signaling 
mTOR is a central regulator of protein turnover, cell cycle, and mRNA translation 
[reviewed in (13)].  Inhibiting or downregulating mTORC1 signaling is suggested to be integral to 
the lifespan extension imparted by CR and chronic rapamycin treatment (11, 12, 14, 28).  





mTORC1 substrates, rpS6 and 4E-BP1, which are involved in ribosome biogenesis and 
translation initiation, respectively.  In a young, fasted cohort (approximately 3 mo of age) of CL 
and CON mice, phosphorylation of the mTORC1 substrates rpS6 and 4E-BP1 was not different 
between 3 mo CL and CON in any tissue, corroborating the protein synthesis measurement in 4 
mo CL.  In contrast to our previous findings in age-matched lifelong CR and chronic rapamycin 
treatment, in 7 mo CL mice rpS6 phosphorylation was greater in heart and liver while 4E-BP1 
phosphorylation was greater in the gastroc complex and TA compared to 7 mo CON (11, 12, 
63).  Together these data suggest the novel finding that mTORC1 activity increases from 4 to 7 
mo of age in the long-lived CL mouse.  
Both mTORC1 and the MAPK substrate RSK can phosphorylate rpS6 at S235/236 and 
4E-BP1 at T37/46 (78, 79).  Therefore, we assessed markers of both mTORC1 (mTOR S2448) 
and RSK (S380) activity.  mTOR phosphorylation at S2448 was not statistically different 
between 7 mo CL and CON in any tissue.  RSK phosphorylation at S380 was not different in 
heart or liver and was undetectable in the gastroc complex and TA.  Given the wide variance in 
some tissues (Fig 5A, C and Fig 6), it is possible that a type II error is limiting our ability to 
observe true differences between RSK and mTORC1 phosphorylation in 7 mo CL and CON.  
However, regardless of the upstream regulator (mTORC1 or RSK), the increase in rpS6 and 4E-
BP1 phosphorylation is consistent with the increased rates of protein synthesis observed in CL 
at 7 mo.  That proteostasis and extended lifespan occur in the CL mouse despite tissue-
dependent increases in mTORC1-related signaling leads us to believe that: 1) a decrease in 
mTORC1 signaling may not be necessary for lifespan extension (29), 2) there are alternative 
pathways that lead to increases in proteostatic mechanisms.   
 
Summary and conclusion 
Here we demonstrate in long-lived CL mice, that a transient energetic stress during the 





4 and 7 mo.  We propose that between 4 and 7 mo there is a switch from growth to 
proteostasis.  We also present novel evidence that in CL mice the increase in proteostatic 
mechanisms at 7 mo is accomplished independently of reduced mTORC1 activity in some 
tissues.  These data highlight the importance of assessing pathways thought to be integral to 
slowed aging, such as mTOR, at multiple time points across the lifespan.   Collectively, we 
expand on the body of evidence establishing CL as a novel model of longevity that may provide 
valuable insights into growth and proteostasis and could aid in the development of novel 
strategies to promote slowed aging. 
 
Addendum to manuscript III 
Retrospective analyses of proteostasis, as evidenced through the comparison of the rate 







Figure 3.1. Protein synthesis in gastroc complex, heart, and liver over 2 weeks in 4 mo and 7 
mo CL and CON.  There were no differences in protein synthesis between groups in any tissue 
between 4 mo CL and 4 mo CON (A, C, E).  Protein synthesis was significantly higher in all 
tissues and fractions in 7 mo CL compared to 7 mo CON (B, D, F).  n=4 per group and fraction 
except liver. Liver 7 mo CL Cyto and Mito n=2 because in 2 animals these fractions were fully 
turned over in the liver (i.e. 100% new) after 2 weeks.  * = p<0.05 for CL vs. CON; # = p<0.05 






Figure 3.2.  DNA synthesis in gastroc complex, heart, and liver over 2 weeks in 4 mo and 7 mo 
CL and CON.  Gastroc complex DNA synthesis was significantly greater in 4 mo CL compared 
to 4 mo CON (A).  Heart DNA synthesis in 4 mo CL tended to be greater (p=0.070) than 4 mo 
CON (A).  There were no differences in liver DNA synthesis between 4 mo animals (A).  In the 7 
mo animals, DNA synthesis was significantly less in CL heart compared to CON (B).  No 
significant differences were observed between 7 mo CL and 7 mo CON in gastroc complex or 
liver (B).  DNA synthesis rates in heart tissues from 4 mo mice were log transformed to 
normalize variance.  n=4 in both ages and groups except in 7 mo CON gastroc complex and 7 
mo CL gastroc complex, heart, and liver n=3 due to one data point being excluded as an outlier.  








Figure 3.3.  Western blotting of mTORC1 substrates rpS6 and 4E-BP1 in fasted 3 mo CL mice.  
No difference between 3 mo CL and CON was found in either rpS6 or 4E-BP1 phosphorylation 
in gastroc complex (A, C) or liver (B, D).  Data are expressed as a ratio of phosphorylated:total 
protein.  β-tubulin is shown to verify equal loading of protein.  Gastroc rpS6 in CL has an n=3 
because one band was not visible to assess and thus was excluded to avoid misrepresenting 







Figure 3.4.  Western blotting of mTORC1 substrates rpS6 and 4E-BP1 in 7 mo CL mice.  rpS6 
phosphorylation was significantly greater in heart and liver in 7 mo CL compared to CON (B and 
C).  4E-BP1 phosphorylation was significantly greater in gastroc complex and tended to be 
greater in heart (0.055) in 7 mo CL compared to 7 mo CON (D and E).  Data are expressed as a 
ratio of phosphorylated:total protein. β-tubulin is shown to verify equal loading of protein.  Liver 







Figure 3.5.  Western blotting of mTOR in 7 mo CL mice.  mTOR phosphorylation at S2448 was 
not statistically significant in any tissue between groups at 7 mo of age (A-C).  Data are 
expressed as a ratio of phosphorylated mTOR to β-tubulin because total mTOR protein was not 







Figure 3.6.  Western blotting of RSK in 7 mo CL mice.  RSK phosphorylation at S380 was not 
different between groups in heart and liver at 7 mo of age (E, F).  We were unable to detect 
S380 RSK in gastroc complex at 7 mo of age.  Data are expressed as a ratio of 
phosphorylated:total protein.  β-tubulin is shown to verify equal loading of protein.  Liver mTOR 







Figure S3.1.  Protein and DNA synthesis in the TA muscle of 7 mo CL mice.  Protein synthesis 
was significantly higher in all fraction in TA of CL compared to CON at 7 mo (A).  No significant 
differences in TA DNA synthesis were observed between 7 mo CL and 7 mo CON (B).  TA 
Protein synthesis n=4 per group and fraction. TA DNA synthesis n=3 due to insufficient sample 
to measure DNA synthesis in one animal. * = p<0.05 for CL vs CON.  # = p<0.05 difference 







Figure S3.2.  Western blotting of rpS6, 4E-BP1, and mTOR in TA of 7 mo CL mice.  rpS6 
phosphorylation tended to be greater in TA of 7 mo CL compared to 7 mo CON (A).  4E-BP1 
phosphorylation was significantly greater in TA of CL compared to CON at 7 mo (B).  mTOR 
phosphorylation at S2448 was not different in TA between 7 mo CL and CON (C).  TA rpS6 in 
CL has an n=3 because one band was not visible to assess and thus was excluded to avoid 
misrepresenting the data.  n=4 per all other groups.  Data are expressed as a ratio of 
phosphorylated:total protein, except for mTOR where S2448 is expressed as a ratio to β-tubulin 
because total mTOR protein was not visible.  β-tubulin is shown for rpS6 and 4E-BP1 blots to 






















In this current series of studies we identified how changes in protein synthesis, an 
essential component of proteostasis, are associated with slowed aging.  Furthermore, these 
studies demonstrate the evolution of our thought process; from measuring protein synthesis 
independently, to considering it in the context of tradeoffs between growth and maintenance, 
then effectively assessing components of proteostasis.  Collectively, we provide evidence to 
suggest that an increase in proteostatic mechanisms is a shared characteristic of slowed aging.       
Past work in our lab on the long-lived caloric restriction model demonstrated that despite 
reduced cellular proliferation and mTORC1 signaling, the synthesis of mitochondrial proteins 
was maintained (11).  We reasoned that energetic savings from reduced cellular proliferation 
may have allowed for the maintenance of mitochondria biogenesis (i.e. somatic maintenance).  
In the first study of the dissertation, we expanded upon our findings in caloric restriction by 
investigating mice chronically administered the mTORC1 inhibitor, and proposed caloric 
restriction mimetic, rapamycin. Here we showed that mitochondrial proteins in skeletal muscle 
were preferentially synthesized despite decreased synthesis in mixed and cytosolic protein 
fractions, cellular proliferation, and mTORC1 (63).  Since reduced protein turnover is thought to 
be causative to the development of the aging phenotype (1-4), we concluded that reduced 
cellular proliferation allowed for energy to be diverted to the somatic maintenance of key 
proteins (15, 16), such as mitochondrial proteins, contributing to slowed aging in both the caloric 
restriction and rapamycin treated mouse models.     
The conclusion of increased somatic maintenance in caloric restriction and Rap models 
required the assumption that either cellular energetics were stabilized or that the energetic 
contribution to metabolism was unchanged (11, 15, 16, 63).  Further reflections upon our 





a component of somatic maintenance, rather than of somatic maintenance itself since we could 
not account for other sources of energetic changes.  Protein synthesis is essential for both 
proliferation/hypertrophy (20-25) and replacing damaged proteins (17-19).  By evaluating our 
data as a ratio of the rate of protein synthesis to the rate of DNA synthesis, we were able to give 
an estimate of whether new proteins were used for equipping new cells or maintenance of 
existing cellular structures (Appendix II).  Under this new framework, in the Snell dwarf mice, we 
compared new proteins synthesized to the rate of cellular proliferation and showed that the 
protein:DNA synthesis ratio was 3-fold higher than it was in control mice across sub-cellular 
fractions, which we take as evidence of an increase in proteostatic mechanisms. 
Finally, we investigated a presumed epigenetic model, the crowded litter mouse, in 
which a transient intervention of reduced nutrient intake during the suckling period extends 
lifespan. We demonstrated that in crowded litter, there is a progression from growth at a 
younger age towards an increase in proteostatic mechanisms later in life. The increase in 
protein synthesis and mTORC1 within crowded litter later in life was in contrast to our other age-
matched investigations in mice undergoing caloric restriction, rapamycin treatment, and Snell 
dwarf mice.  Through comparing the increased protein synthesis to our other finding of 
unchanged DNA synthesis in crowded litter, we illustrated a similar increase as in our previous 
models in the new protein to new DNA ratio, indicative of proteostatic mechanisms.  These data 
in crowded litter suggest the novel finding that increases in proteostatic mechanisms can be 
independent of decreased mTORC1.    
To summarize, our objective was to understand the role that changes in protein 
synthesis have in slowed aging (Fig 4.1).  We have demonstrated that decreased mTORC1 in 
some models of long-life does not necessarily equate to decreased protein synthesis across 
sub-cellular fractions and tissues.  Discerning specific proteins and the mechanism(s) by which 
a subset of proteins can be preferentially synthesized despite decreases in protein synthesis in 





aging.  By considering protein synthesis rates in relation to the synthesis of new DNA, we 
present novel insight into proteostasis. We demonstrate that increased proteostatic mechanisms 
is a shared characteristic of multiple unique models of long-life and therefore has potential for 








Figure 4.1.  Summary of protein and DNA synthesis, Rate of new Pro:DNA ratio, and mTORC1-
related signaling in all models and tissues.  Arrows indicate the change compared to 
corresponding control.  Findings that were statistically not different from their corresponding 


















1. Stadtman, E. R. (1992) Protein oxidation and aging. Science 257, 1220-1224 
2. Stadtman, E. R. (1988) Protein modification in aging. J Gerontol 43, B112-120 
3. Rooyackers, O. E., Adey, D. B., Ades, P. A., and Nair, K. S. (1996) Effect of age on in 
vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad 
Sci U S A 93, 15364-15369 
4. Orgel, L. E. (1963) The maintenance of the accuracy of protein synthesis and its 
relevance to ageing. Proc Natl Acad Sci U S A 49, 517-521 
5. Rattan, S. I. (1996) Synthesis, modifications, and turnover of proteins during aging. Exp 
Gerontol 31, 33-47 
6. Balch, W. E., Morimoto, R. I., Dillin, A., and Kelly, J. W. (2008) Adapting proteostasis for 
disease intervention. Science 319, 916-919 
7. Austad, S. N. (2010) Methusaleh's Zoo: how nature provides us with clues for extending 
human health span. J Comp Pathol 142 Suppl 1, S10-21 
8. Perez, V. I., Buffenstein, R., Masamsetti, V., Leonard, S., Salmon, A. B., Mele, J., 
Andziak, B., Yang, T., Edrey, Y., Friguet, B., Ward, W., Richardson, A., and Chaudhuri, 
A. (2009) Protein stability and resistance to oxidative stress are determinants of 
longevity in the longest-living rodent, the naked mole-rat. Proc Natl Acad Sci U S A 106, 
3059-3064 
9. Salmon, A. B., Leonard, S., Masamsetti, V., Pierce, A., Podlutsky, A. J., Podlutskaya, N., 
Richardson, A., Austad, S. N., and Chaudhuri, A. R. (2009) The long lifespan of two bat 
species is correlated with resistance to protein oxidation and enhanced protein 
homeostasis. FASEB J 23, 2317-2326 
10. Treaster, S. B., Ridgway, I. D., Richardson, C. A., Gaspar, M. B., Chaudhuri, A. R., and 
Austad, S. N. (2013) Superior proteome stability in the longest lived animal. Age (Dordr) 
epub ahead of print. 
11. Miller, B. F., Robinson, M. M., Bruss, M. D., Hellerstein, M., and Hamilton, K. L. (2012) A 
comprehensive assessment of mitochondrial protein synthesis and cellular proliferation 
with age and caloric restriction. Aging Cell 11, 150-161 
12. Miller, B. F., Robinson, M. M., Reuland, D. J., Drake, J. C., Peelor, F. F., 3rd, Bruss, M. 
D., Hellerstein, M. K., and Hamilton, K. L. (2012) Calorie Restriction Does Not Increase 
Short-term or Long-term Protein Synthesis. J Gerontol A Biol Sci Med Sci 68, 530-538 
13. Laplante, M., and Sabatini, D. M. (2012) mTOR signaling in growth control and disease. 
Cell 149, 274-293 
14. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, 
N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., Pahor, M., Javors, M. A., Fernandez, 
E., and Miller, R. A. (2009) Rapamycin fed late in life extends lifespan in genetically 
heterogeneous mice. Nature 460, 392-395 
15. Kirkwood, T. L., Kapahi, P., and Shanley, D. P. (2000) Evolution, stress, and longevity. J 
Anat 197 Pt 4, 587-590 
16. Kirkwood, T. B. (1977) Evolution of ageing. Nature 270, 301-304 
17. Mary, J., Vougier, S., Picot, C. R., Perichon, M., Petropoulos, I., and Friguet, B. (2004) 
Enzymatic reactions involved in the repair of oxidized proteins. Exp Gerontol 39, 1117-
1123 
18. Mortimore, G. E., and Poso, A. R. (1987) Intracellular protein catabolism and its control 





19. Poppek, D., and Grune, T. (2006) Proteasomal defense of oxidative protein 
modifications. Antioxid Redox Signal 8, 173-184 
20. Jorgensen, P., and Tyers, M. (2004) How cells coordinate growth and division. Curr Biol 
14, R1014-1027 
21. Grebien, F., Dolznig, H., Beug, H., and Mullner, E. W. (2005) Cell size control: new 
evidence for a general mechanism. Cell Cycle 4, 418-421 
22. White, R. B., Bierinx, A. S., Gnocchi, V. F., and Zammit, P. S. (2010) Dynamics of 
muscle fibre growth during postnatal mouse development. BMC Dev Biol 10, 21 
23. Allen, D. L., Roy, R. R., and Edgerton, V. R. (1999) Myonuclear domains in muscle 
adaptation and disease. Muscle Nerve 22, 1350-1360 
24. Pavlath, G. K., Rich, K., Webster, S. G., and Blau, H. M. (1989) Localization of muscle 
gene products in nuclear domains. Nature 337, 570-573 
25. Collins, C. A., Olsen, I., Zammit, P. S., Heslop, L., Petrie, A., Partridge, T. A., and 
Morgan, J. E. (2005) Stem cell function, self-renewal, and behavioral heterogeneity of 
cells from the adult muscle satellite cell niche. Cell 122, 289-301 
26. Flurkey, K., Papaconstantinou, J., and Harrison, D. E. (2002) The Snell dwarf mutation 
Pit1(dw) can increase life span in mice. Mech Ageing Dev 123, 121-130 
27. Hsieh, C. C., DeFord, J. H., Flurkey, K., Harrison, D. E., and Papaconstantinou, J. 
(2002) Effects of the Pit1 mutation on the insulin signaling pathway: implications on the 
longevity of the long-lived Snell dwarf mouse. Mech Ageing Dev 123, 1245-1255 
28. Hsieh, C. C., and Papaconstantinou, J. (2004) Akt/PKB and p38 MAPK signaling, 
translational initiation and longevity in Snell dwarf mouse livers. Mech Ageing Dev 125, 
785-798 
29. Sun, L., Sadighi Akha, A. A., Miller, R. A., and Harper, J. M. (2009) Life-span extension 
in mice by preweaning food restriction and by methionine restriction in middle age. J 
Gerontol A Biol Sci Med Sci 64, 711-722 
30. Lee, H. C., and Wei, Y. H. (2012) Mitochondria and aging. Adv Exp Med Biol 942, 311-
327 
31. Miller, B. F., and Hamilton, K. L. (2012) A perspective on the determination of 
mitochondrial biogenesis. Am J Physiol Endocrinol Metab 302, E496-499 
32. Ma, X. M., and Blenis, J. (2009) Molecular mechanisms of mTOR-mediated translational 
control. Nat Rev Mol Cell Biol 10, 307-318 
33. Bentzinger, C. F., Romanino, K., Cloetta, D., Lin, S., Mascarenhas, J. B., Oliveri, F., Xia, 
J., Casanova, E., Costa, C. F., Brink, M., Zorzato, F., Hall, M. N., and Ruegg, M. A. 
(2008) Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic 
changes and results in muscle dystrophy. Cell Metab 8, 411-424 
34. Sengupta, S., Peterson, T. R., and Sabatini, D. M. (2010) Regulation of the mTOR 
complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40, 310-322 
35. Powers, R. W., 3rd, Kaeberlein, M., Caldwell, S. D., Kennedy, B. K., and Fields, S. 
(2006) Extension of chronological life span in yeast by decreased TOR pathway 
signaling. Genes Dev 20, 174-184 
36. Jia, K., Chen, D., and Riddle, D. L. (2004) The TOR pathway interacts with the insulin 
signaling pathway to regulate C. elegans larval development, metabolism and life span. 
Development 131, 3897-3906 
37. Kapahi, P., Zid, B. M., Harper, T., Koslover, D., Sapin, V., and Benzer, S. (2004) 
Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling 
pathway. Curr Biol 14, 885-890 
38. Miller, R. A., Harrison, D. E., Astle, C. M., Baur, J. A., Boyd, A. R., de Cabo, R., 
Fernandez, E., Flurkey, K., Javors, M. A., Nelson, J. F., Orihuela, C. J., Pletcher, S., 





(2011) Rapamycin, but not resveratrol or simvastatin, extends life span of genetically 
heterogeneous mice. J Gerontol A Biol Sci Med Sci 66, 191-201 
39. Chung, J., Kuo, C. J., Crabtree, G. R., and Blenis, J. (1992) Rapamycin-FKBP 
specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein 
kinases. Cell 69, 1227-1236 
40. Yip, C. K., Murata, K., Walz, T., Sabatini, D. M., and Kang, S. A. (2010) Structure of the 
human mTOR complex I and its implications for rapamycin inhibition. Mol Cell 38, 768-
774 
41. Pedersen, S., Celis, J. E., Nielsen, J., Christiansen, J., and Nielsen, F. C. (1997) Distinct 
repression of translation by wortmannin and rapamycin. Eur J Biochem 247, 449-456 
42. Huo, Y., Iadevaia, V., Yao, Z., Kelly, I., Cosulich, S., Guichard, S., Foster, L. J., and 
Proud, C. G. (2012) Stable isotope-labelling analysis of the impact of inhibition of the 
mammalian target of rapamycin on protein synthesis. Biochem J 444, 141-151 
43. Brown, E. J., Albers, M. W., Shin, T. B., Ichikawa, K., Keith, C. T., Lane, W. S., and 
Schreiber, S. L. (1994) A mammalian protein targeted by G1-arresting rapamycin-
receptor complex. Nature 369, 756-758 
44. Paturi, S., Gutta, A. K., Katta, A., Kakarla, S. K., Arvapalli, R. K., Gadde, M. K., 
Nalabotu, S. K., Rice, K. M., Wu, M., and Blough, E. (2010) Effects of aging and gender 
on muscle mass and regulation of Akt-mTOR-p70s6k related signaling in the F344BN rat 
model. Mech Ageing Dev 131, 202-209 
45. Busch, R., Kim, Y. K., Neese, R. A., Schade-Serin, V., Collins, M., Awada, M., Gardner, 
J. L., Beysen, C., Marino, M. E., Misell, L. M., and Hellerstein, M. K. (2006) 
Measurement of protein turnover rates by heavy water labeling of nonessential amino 
acids. Biochim Biophys Acta 1760, 730-744 
46. Neese, R. A., Misell, L. M., Turner, S., Chu, A., Kim, J., Cesar, D., Hoh, R., Antelo, F., 
Strawford, A., McCune, J. M., Christiansen, M., and Hellerstein, M. K. (2002) 
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the 
deoxyribose moiety of DNA. Proc Natl Acad Sci U S A 99, 15345-15350 
47. Robinson, M. M., Richards, J. C., Hickey, M. S., Moore, D. R., Phillips, S. M., Bell, C., 
and Miller, B. F. (2010) Acute {beta}-adrenergic stimulation does not alter mitochondrial 
protein synthesis or markers of mitochondrial biogenesis in adult men. Am J Physiol 
Regul Integr Comp Physiol 298, R25-33 
48. Fanara, P., Turner, S., Busch, R., Killion, S., Awada, M., Turner, H., Mahsut, A., 
Laprade, K. L., Stark, J. M., and Hellerstein, M. K. (2004) In vivo measurement of 
microtubule dynamics using stable isotope labeling with heavy water. Effect of taxanes. 
J Biol Chem 279, 49940-49947 
49. Robinson, M. M., Turner, S. M., Hellerstein, M. K., Hamilton, K. L., and Miller, B. F. 
(2011) Long-term synthesis rates of skeletal muscle DNA and protein are higher during 
aerobic training in older humans than in sedentary young subjects but are not altered by 
protein supplementation. FASEB J 25, 3240-3249  
50. Bjedov, I., Toivonen, J. M., Kerr, F., Slack, C., Jacobson, J., Foley, A., and Partridge, L. 
(2010) Mechanisms of life span extension by rapamycin in the fruit fly Drosophila 
melanogaster. Cell Metab 11, 35-46 
51. Wilkinson, J. E., Burmeister, L., Brooks, S. V., Chan, C. C., Friedline, S., Harrison, D. E., 
Hejtmancik, J. F., Nadon, N., Strong, R., Wood, L. K., Woodward, M. A., and Miller, R. A. 
(2012) Rapamycin slows aging in mice. Aging Cell 11, 675-682 
52. Chen, W. Q., Zhong, L., Zhang, L., Ji, X. P., Zhang, M., Zhao, Y. X., Zhang, C., and 
Zhang, Y. (2009) Oral rapamycin attenuates inflammation and enhances stability of 






53. Halloran, J., Hussong, S. A., Burbank, R., Podlutskaya, N., Fischer, K. E., Sloane, L. B., 
Austad, S. N., Strong, R., Richardson, A., Hart, M. J., and Galvan, V. (2012) Chronic 
inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-
cognitive components of behavior throughout lifespan in mice. Neuroscience 223, 102-
113 
54. Burkle, A. (2001) Mechanisms of ageing. Eye (Lond) 15, 371-375 
55. Kim, J., Kundu, M., Viollet, B., and Guan, K. L. (2011) AMPK and mTOR regulate 
autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13, 132-141 
56. Brown-Borg, H. M., Borg, K. E., Meliska, C. J., and Bartke, A. (1996) Dwarf mice and the 
ageing process. Nature 384, 33 
57. Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., 
Davis, J. G., Salmon, A. B., Richardson, A., Ahima, R. S., Guertin, D. A., Sabatini, D. M., 
and Baur, J. A. (2012) Rapamycin-induced insulin resistance is mediated by mTORC2 
loss and uncoupled from longevity. Science 335, 1638-1643 
58. Choo, A. Y., Yoon, S. O., Kim, S. G., Roux, P. P., and Blenis, J. (2008) Rapamycin 
differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA 
translation. Proc Natl Acad Sci U S A 105, 17414-17419 
59. Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., 
Sim, T., Sabatini, D. M., and Gray, N. S. (2009) An ATP-competitive mammalian target 
of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 
284, 8023-8032 
60. Holz, M. K., Ballif, B. A., Gygi, S. P., and Blenis, J. (2005) mTOR and S6K1 mediate 
assembly of the translation preinitiation complex through dynamic protein interchange 
and ordered phosphorylation events. Cell 123, 569-580 
61. Verdijk, L. B., Koopman, R., Schaart, G., Meijer, K., Savelberg, H. H., and van Loon, L. 
J. (2007) Satellite cell content is specifically reduced in type II skeletal muscle fibers in 
the elderly. Am J Physiol Endocrinol Metab 292, E151-157 
62. Turturro, A., Witt, W. W., Lewis, S., Hass, B. S., Lipman, R. D., and Hart, R. W. (1999) 
Growth curves and survival characteristics of the animals used in the Biomarkers of 
Aging Program. J Gerontol A Biol Sci Med Sci 54, B492-501 
63. Drake, J. C., Peelor, F. F., 3rd, Biela, L. M., Watkins, M. K., Miller, R. A., Hamilton, K. L., 
and Miller, B. F. (2013) Assessment of Mitochondrial Biogenesis and mTORC1 Signaling 
During Chronic Rapamycin Feeding in Male and Female Mice. J Gerontol A Biol Sci Med 
Sci 68, 1493-1501 
64. Flurkey, K., Papaconstantinou, J., Miller, R. A., and Harrison, D. E. (2001) Lifespan 
extension and delayed immune and collagen aging in mutant mice with defects in growth 
hormone production. Proc Natl Acad Sci U S A 98, 6736-6741 
65. Selman, C., Tullet, J. M., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, 
M., Al-Qassab, H., Carmignac, D., Ramadani, F., Woods, A., Robinson, I. C., Schuster, 
E., Batterham, R. L., Kozma, S. C., Thomas, G., Carling, D., Okkenhaug, K., Thornton, 
J. M., Partridge, L., Gems, D., and Withers, D. J. (2009) Ribosomal protein S6 kinase 1 
signaling regulates mammalian life span. Science 326, 140-144 
66. Gingold, H., and Pilpel, Y. (2011) Determinants of translation efficiency and accuracy. 
Mol Syst Biol 7, 481 
67. Conn, C. S., and Qian, S. B. (2013) Nutrient signaling in protein homeostasis: an 
increase in quantity at the expense of quality. Sci Signal 6, ra24 
68. Wu, P., Jiang, C., Shen, Q., and Hu, Y. (2009) Systematic gene expression profile of 
hypothalamus in calorie-restricted mice implicates the involvement of mTOR signaling in 





69. Kaeberlein, M., Powers, R. W., 3rd, Steffen, K. K., Westman, E. A., Hu, D., Dang, N., 
Kerr, E. O., Kirkland, K. T., Fields, S., and Kennedy, B. K. (2005) Regulation of yeast 
replicative life span by TOR and Sch9 in response to nutrients. Science 310, 1193-1196 
70. Robida-Stubbs, S., Glover-Cutter, K., Lamming, D. W., Mizunuma, M., Narasimhan, S. 
D., Neumann-Haefelin, E., Sabatini, D. M., and Blackwell, T. K. (2012) TOR signaling 
and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell 
Metab 15, 713-724 
71. Hales, C. N., and Barker, D. J. (2001) The thrifty phenotype hypothesis. Br Med Bull 60, 
5-20 
72. Tarry-Adkins, J. L., Martin-Gronert, M. S., Chen, J. H., Cripps, R. L., and Ozanne, S. E. 
(2008) Maternal diet influences DNA damage, aortic telomere length, oxidative stress, 
and antioxidant defense capacity in rats. FASEB J 22, 2037-2044 
73. Chen, J. H., Martin-Gronert, M. S., Tarry-Adkins, J., and Ozanne, S. E. (2009) Maternal 
protein restriction affects postnatal growth and the expression of key proteins involved in 
lifespan regulation in mice. PLoS One 4, e4950 
74. Habbout, A., Li, N., Rochette, L., and Vergely, C. (2013) Postnatal overfeeding in 
rodents by litter size reduction induces major short- and long-term pathophysiological 
consequences. J Nutr 143, 553-562 
75. Steinbaugh, M. J., Sun, L. Y., Bartke, A., and Miller, R. A. (2012) Activation of genes 
involved in xenobiotic metabolism is a shared signature of mouse models with extended 
lifespan. Am J Physiol Endocrinol Metab 303, E488-495 
76. Li, G., Kohorst, J. J., Zhang, W., Laritsky, E., Kunde-Ramamoorthy, G., Baker, M. S., 
Fiorotto, M. L., and Waterland, R. A. (2013) Early Postnatal Nutrition Determines Adult 
Physical Activity and Energy Expenditure in Female Mice. Diabetes 62, 2773-2783 
77. Reynolds, T. H. t., Bodine, S. C., and Lawrence, J. C., Jr. (2002) Control of Ser2448 
phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle 
load. J Biol Chem 277, 17657-17662 
78. Kroczynska, B., Joshi, S., Eklund, E. A., Verma, A., Kotenko, S. V., Fish, E. N., and 
Platanias, L. C. (2011) Regulatory effects of ribosomal S6 kinase 1 (RSK1) in 
IFNlambda signaling. J Biol Chem 286, 1147-1156 
79. Roux, P. P., Shahbazian, D., Vu, H., Holz, M. K., Cohen, M. S., Taunton, J., Sonenberg, 
N., and Blenis, J. (2007) RAS/ERK signaling promotes site-specific ribosomal protein S6 
phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem 282, 
14056-14064 
80. Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S., 
Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., Jovinge, S., and Frisen, J. (2009) 
Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 
81. Senyo, S. E., Steinhauser, M. L., Pizzimenti, C. L., Yang, V. K., Cai, L., Wang, M., Wu, 
T. D., Guerquin-Kern, J. L., Lechene, C. P., and Lee, R. T. (2013) Mammalian heart 
renewal by pre-existing cardiomyocytes. Nature 493, 433-436 
82. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., 
McKay, R., Nadal-Ginard, B., Bodine, D. M., Leri, A., and Anversa, P. (2001) Bone 
marrow cells regenerate infarcted myocardium. Nature 410, 701-705 
83. Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, 
H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B., and 
Anversa, P. (2003) Adult cardiac stem cells are multipotent and support myocardial 
regeneration. Cell 114, 763-776 
84. Walsh, S., Ponten, A., Fleischmann, B. K., and Jovinge, S. (2010) Cardiomyocyte cell 
cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei. 





85. Dellavalle, A., Sampaolesi, M., Tonlorenzi, R., Tagliafico, E., Sacchetti, B., Perani, L., 
Innocenzi, A., Galvez, B. G., Messina, G., Morosetti, R., Li, S., Belicchi, M., Peretti, G., 
Chamberlain, J. S., Wright, W. E., Torrente, Y., Ferrari, S., Bianco, P., and Cossu, G. 
(2007) Pericytes of human skeletal muscle are myogenic precursors distinct from 
satellite cells. Nat Cell Biol 9, 255-267 
86. Mitchell, K. J., Pannerec, A., Cadot, B., Parlakian, A., Besson, V., Gomes, E. R., 
Marazzi, G., and Sassoon, D. A. (2010) Identification and characterization of a non-
satellite cell muscle resident progenitor during postnatal development. Nat Cell Biol 12, 
257-266 
87. Zheng, B., Cao, B., Crisan, M., Sun, B., Li, G., Logar, A., Yap, S., Pollett, J. B., Drowley, 
L., Cassino, T., Gharaibeh, B., Deasy, B. M., Huard, J., and Peault, B. (2007) 
Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat 
Biotechnol 25, 1025-1034 
88. Moss, F. P., and Leblond, C. P. (1971) Satellite cells as the source of nuclei in muscles 
of growing rats. Anat Rec 170, 421-435 
89. Drake, J. C., Bruns, D. R., Peelor, F. F., 3rd, Biela, L. M., Miller, R. A., Hamilton, K. L., 
Miller, B. F.  A novel protein and DNA synthetic response in the long-lived crowded litter 






































Increased protein synthesis is proposed as a mechanism of lifespan extension during 
caloric restriction (CR). We hypothesized that CR does not increase protein synthesis in all 
tissues and protein fractions, and that any increased protein synthesis with CR would be due to 
an increased anabolic effect of feeding.  We used short (4 hour) and long-term (6 weeks) 
methods to measure in vivo protein synthesis in lifelong ad libitum (AL) and CR mice.  We did 
not detect an acute effect of feeding on protein synthesis in any tissue or fraction, while liver 
mitochondrial protein synthesis was lower in CR mice versus AL mice.  mTOR signaling was 
repressed in liver and heart from CR mice indicative of energetic stress and suppression of 
growth. Our main findings were that CR did not increase rates of mixed protein synthesis over 
the long term or in response to acute feeding, and protein synthesis was maintained despite 
decreased mTOR signaling. 
Introduction 
 
 Caloric restriction (CR) without malnutrition is an intervention that consistently increases 
maximum lifespan across a variety of species.  CR can increase mean and maximum lifespan 
by 40%, and since it is relatively simple and the outcomes robust, it is a good model to study the 
mechanisms of aging (1). Consistent with evolutionary theories of aging, it is thought that CR 
induces a state of somatic maintenance, which is anti-aging, rather than the reproductive state 
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that is pro-aging (2).  Somatic maintenance implies an increase in repair processes, which is 
supported by evidence that CR inhibits the accumulation of oxidatively damaged proteins (3), 
increases respiratory control (4), increases mitochondria efficiency (5), and increases 
autophagy (6).  
It has long been recognized that protein and energy metabolism are dependent on each 
other (7-9).  The process of protein synthesis is energetically expensive (10) requiring the 
greatest proportion (20.5%) of basal respiratory rate in isolated cells (11).  In times of energy 
deficit, either absolute energy deficiency or decreased energetic flux, it is not energetically 
economical to build up large stores of protein.  Given the dependence of protein turnover on 
energy status, it is surprising that during CR protein turnover is observed to increase in some 
reports (4, 12-14), and that CR increases transcription of genes associated with increased 
protein turnover (15).  
Protein turnover is tissue specific. In a series of studies on male Sprague-Dawley rats 
maintained on 50% CR from 3 weeks of age, there was an increase in whole body protein 
turnover (13), variable results in tibialis anterior or soleus muscle protein turnover (12) and no 
change in lung protein turnover (16).  Recently, it has been reported that CR does not change 
actin and myosin turnover in either tibialis anterior or soleus muscles in male Wistar rats on a 
40% restricted diet for 5 months (4) and that short-term (7 day) CR of 40% in male Wistar rats 
decreases protein turnover in liver and skeletal muscle, but is maintained in heart (17). We 
(Price et al, Manuscript submitted) used an LC-MS/MS technique, in which in vivo tissue protein 
synthesis rates are measured by MIDA analysis of D2O incorporation into peptides fragments, to 
measure dynamics of the global proteome and found a marked reduction in synthesis rates of 
almost all proteins in the hepatic proteome, particularly mitochondrial proteins, in rats 
maintained on chronic CR. In our previous investigation into B6D2F1 mice on lifelong 40% CR, 
it was found that mitochondrial protein synthesis was maintained with CR compared to AL in 





that CR increases protein turnover (19, 20), the issue does not seem truly resolved, since 
tissue-specific responses are not consistent.   
Much of what we currently know about the rates of protein turnover was obtained by the 
use of stable or radioactive isotopic tracers.  In a series of experiments it was determined that 
the commonly used method of using flooding doses of essential amino acid tracers were 
increasing protein synthesis rates (21, 22), an intrinsic limitation based on principles of tracer 
methodology since the tracer changed the process that was being measured.  Subsequent 
studies have identified leucine-stimulated mTOR signaling and downstream activation of 
translation initiation factors as the means by which a large amount of essential amino acids 
stimulated protein synthesis (23).  As discussed previously, in general, protein synthesis has 
been reported to increase with CR although changes are not uniform throughout tissues (4, 12-
14, 16, 19, 20, 24).  The reports from which these conclusions are drawn (4, 12-14, 16, 24) have 
all used a flooding dose of an essential amino acid.  The flooding doses used in these studies 
were over twice what is observed to stimulate protein synthesis rates in humans (21, 22, 25).  
Therefore, the method itself may be simulating feeding, and the measured response is not only 
the effect of CR, but also reflects the effects of CR on tissue-specific responses to feeding. Also, 
since some tissues, such as skeletal muscle, are sensitive to a feeding stimulus while others are 
not, the interpretation of tissue-specific protein turnover measurements over the long-term 
becomes complicated (26). 
An additional method to measure tissue protein turnover rates has been established that 
circumvents the problem of precursor labeling, namely stable isotopically labeled water 
(2H2O)(27-29).  The 2H2O equilibrates throughout all tissues within an hour and decays with a 
half-life of one week (30). The long-term labeling design allows for the determination of average 
(or cumulative) effects over time, which is an advantage when studying long-term treatments. 
Importantly, the technique has been shown to be reliable and valid in a variety of tissues (29).  





32).  This method relies on a flooding dose of 2H2O administered similarly to a flooding dose of 
amino acids, but without the simultaneous stimulation of mTOR and translation initiation as with 
essential amino acids.   
In this study, our aims were to understand the effects CR on tissue specific protein 
turnover.  We hypothesized that CR does not increase protein synthesis in all protein fractions 
and tissues because of the energy requirements of mRNA translation.  Further, we 
hypothesized that if a nutrient sensitive tissue did increase protein synthesis it would be due to 
increased anabolic responses to acute feeding.  To address our hypothesis, we used a 
combination of 2H2O methods to measure in vivo protein synthesis in a variety of tissues in ad 
libitum (AL) and CR mice.  Our use of 2H2O methods avoided the independent effect of flooding 
doses of essential amino acid that confound interpretation of previous studies.  
Materials and Methods 
 
Overall study design  
 Male B6D2F1 mice from the National Institute of Aging (NIA) calorically restricted (CR) 
colony and age-matched ad lib controls (AL) were used for all aspects of the study. Lifelong CR 
mice were maintained at the NIA colony at 40% food restricted compared to AL.  Mice were 
purchased at 6, 12, and 21 months of age into both AL and CR groups and were studied as one 
group. CR animals were maintained on NIH-31/NIA Fortified Diet while AL animals were 
maintained on NIH-31 diet. Two separate cohorts were used for the study (Fig. 1).  The first 
cohort was used after a one-week acclimatization to housing conditions, while the second 
cohort was used after a one-week acclimatization and six-week assessment of synthesis 
(described below). The animals were individually housed and consumed the same absolute 
quantity of NIA diets while being maintained until experimentation at the CSU Laboratory Animal 
Resource Center, at 18-26°C (dry bulb), 30-70% humidity, and a 12-hr light/dark cycle.  All 





described in the Animal Welfare Act regulations, the Guide for the Care and Use of Laboratory 
Animals and the Guide for the Care and Use of Agricultural Animals in Agricultural Research 
and Teaching and were approved by the CSU Animal Care and Use Committee (protocol #09-
022A).  
 Sixteen hours prior to sacrifice, all food, but not water, was removed from the animals’ 
cages (Fig. 1).  Animals were anesthetized with an intraperitoneal (i.p.) injection of sodium 
pentobarbital.  Blood was then obtained by cardiac puncture (approximately 1 ml) followed by 
rapid excision and cryopreservation of the heart, liver, the posterior aspect of both the distal 
hind limbs (mixed skeletal muscle).  All tissues were stored at -80°C until analysis.   
 
Labeled water  
 The use of heavy water (2H2O) allows simultaneous assessment of multiple synthetic 
processes.  In this case we assessed the synthesis of protein in three tissues:  heart, liver, and 
skeletal muscle.  Animals in cohort 1 were studied in the short-term by receiving an i.p. injection 
of 20 µl/gm body weight 99% 2H2O followed one hour later by an oral gavage of saline (Fasted) 
or an amino acid solution (Fed; Aminocyn , 0.05 mg/gm body weight, Aminocyn II 15%, Hospira 
Inc, Lake Forest, IL).  The amino acid dose was roughly equivalent to those used in previous 
studies of CR (4, 12-14, 16, 24).  Both saline and Aminocyn were enriched 4% with 2H2O.  
Three hours after the oral gavage tissues were collected.  Animals in cohort 2 were studied over 
the long-term and received an i.p. injection of 99% enriched 2H2O calculated to enrich the body 
water pool (assumed 60% of body weight) to 5%.  Animals were then allowed to drink ad libitum 
water enriched to 4% for the next 6 weeks.   
 
Tissue isolation - Because of the heterogeneity of protein synthetic responses within a tissue, 
heart, liver, and skeletal muscle were fractionated according to our previously published 





isolation buffer (100 mM KCl, 40 mM Tris HCl, 10 mM Tris Base, 5 mM MgCl2, 1 mM EDTA, 1 
mM ATP, pH=7.5) with phosphatase and protease inhibitors (HALT, Thermo Scientific) using a 
bead homogenizer (Next Advance Inc, Averill Park NY). The homogenate was centrifuged at 
800g for 10 minutes to pellet a mixed protein fraction (Mixed). The supernatant from the low-
speed spin was carefully removed and centrifuged (9000 x g) for 10 minutes to pellet a 
mitochondrial enriched fraction (Mito).  The crude Mito pellet was washed and suspended in 200 
µl of solution 2 (100 mM KCl, 10 mM Tris-HCl, 10 mM Tris base, 1 mM MgSO4, 0.1 mM EDTA, 
0.02 mM ATP, and 1.5% BSA, pH 7.4), then centrifuged (8000 x g, 10 minutes, 4°C).  The pellet 
was washed a second time, suspended in 100 µl of solution 2 and centrifuged (6000 x g, 10 
minutes, 4°C). The final Mixed and Mito pellets were washed with 500 µl of 100% ethanol, 
centrifuged (1000 x g, 30 seconds, 4°C), and rinsed with water (repeated twice).  Protein pellets 
were solubilized in 1N NaOH (50°C, 15 minutes) and hydrolyzed into free amino acids (6 M HCl, 
120°C, 24 hours). 
 
Preparation of analytes for mass spectrometric analyses - The hydrolysates from the tissue 
isolations were ion-exchanged, dried under vacuum and then suspended in 1 ml of 50% 
acetonitrile, 50 mM K2HPO4, pH 11. Twenty microliters of pentafluorobenzyl bromide (Pierce 
Scientific, Rockford, IL, USA) were added, and the sealed mixture was incubated at 100°C for 1 
h. Derivatives were extracted into ethyl acetate and the organic layer was removed and dried by 
addition of solid Na2SO4 followed by vacuum centrifugation.  
GC-MS analysis of derivatized amino acids - Using negative chemical ionization (NCI), 
derivatized amino acids (AA) were analyzed on a DB225 gas chromatograph column. The 
starting temperature was 100°C, increasing 10°C per minute to 220°C.  The mass spectrometry 
used NCI with helium as the carrier gas and methane as the reagent gas.  The mass-to-charge 





di(pentafluorobenzyl)alaninate derivative.  In all cases, these mass-to-charge ratios represented 
the primary daughter ions that included all of the original hydrocarbon bonds from the given 
amino acid. 2H enrichment was calculated as described previously (35).  The newly synthesized 
fraction (f) of muscle proteins was calculated from the true precursor enrichment (p) using mass 
isotopomer distribution analysis [MIDA (36, 37)].  Protein synthesis was calculated as the 
change in enrichment of deuterium labeled alanine (37) bound in muscle proteins over the entire 
labeling period and expressed as the common unit for protein synthesis rates (%/hr).  
Western blot analyses   
From Animals in Cohort 1, approximately 30 mg of frozen tissue was homogenized (Next 
Advance Inc, Averill Park NY) in 500 µl of ice-cold buffer (100 mM KCl, 40 mM Tris HCl, 10 mM 
Tris Base, 5 mM MgCl2, 1 mM EDTA, 1 mM ATP, pH 7.4) and commercial protease with 
phosphate inhibitor (Halt, Thermo Fisher, Rockford IL).  Samples were centrifuged (10 minutes, 
10000g, 4°C), then the supernatant was removed and protein concentration determined using a 
bicinchoninic acid assay (Thermo Fisher, Rockford IL).  Samples were diluted to the same 
concentration, boiled with Laemmlli buffer, then 20 µg (heart and skeletal muscle) or 30 µg 
(liver) were separated using 12% SDS-PAGE at 200V.  Proteins were transferred at 4°C (100 V 
for 60 minutes in 20% w/v methanol, 0.02 % w/v SDS, 25 mM Tris, 192 mM glycine, pH 8.3) to 
nitrocellulose paper and incubated in Superblock (Thermo Fisher, Rockford IL) for one hour at 
room temperature.  Antibodies were purchased from Cell Signaling Technologies (Boston, MA, 
USA; RpS6 #2217, RpS6 phospho-Ser[240/244] #2215, 4E-BP-1 #9452, phospho-4E-BP-
1[Thr37/46] #9459).  Blots were incubated overnight with primary antibodies diluted 1:250 in 
Superblock reagent.  Blots were washed in tris-buffered saline with Tween and incubated with 
anti-rabbit HRP conjugated secondary antibody diluted 1:2000 in Superblock with subsequent 
chemiluminescence detection (West Dura, Pierce, Rockford, IL, USA).  Images were captured 





probed for phosphorylated proteins first, then stripped and re-probed for total protein.  Equal 
loading was verified using ponceau-s staining as well as actin antibodies (sc-8432, Santa Cruz 
Biotechnology, Santa Cruz CA). 
 
Statistics 
Statistical analysis was performed using SPSS (V19, IBM SPSS, Somers, NY). Our 
initial goal was to also examine whether there were changes in protein turnover at three 
different ages.  We did not detect a difference with age in our primary outcomes and therefore 
collapsed the ages into AL and CR groups to increase the number of animals in each 
comparison and increase statistical power. The effects of treatment (AL vs. CR), and condition 
(Fasted vs. Fed) were examined by two-by-two analysis of variance (ANOVA) with a priori linear 
contrasts.  In conditions where data were unequally variable, appropriate transformations were 
performed.  For comparing AL and CR without respect to feeding (long-term and collapsed 
short-term data), a two-tailed unpaired t-test was used.  Significance was set at p ≤ 0.05.  Data 
are presented as means ± SEM.  
Results 
 
Liver, heart and skeletal muscle mixed protein synthesis were assessed in the four-hour 
period after feeding an amino acid (or saline) solution, and over a six-week period.  In the short-
term cohort there were no significant increases in mixed protein synthesis in all three tissues 
with feeding and no differences between AL and CR animals (Figure 2A).  In liver, mitochondrial 
protein synthesis was lower in CR animals when compared to AL animals (Figure 2B) in both 
the fasted and fed states.  There were no differences between AL and CR animals for heart or 
skeletal muscle mitochondrial protein synthesis.  When all three tissues were assessed over the 





synthesis (Figure 2C), although liver mixed protein was 100% newly replaced in this time period 
and therefore it is not possible to differentiate rates of synthesis between treatments.   
All three tissues were assessed for activation of the mTOR pathway by Western blotting 
for phospho and total 4E-BP-1 and RpS6.  In liver, phospho-4E-BP-1 (Figure 3A) and 
phospho:total (Figure 3B) were decreased with CR as was phospho-RpS6 (Figure 3D) and total 
(Figure 3E).  For heart phospho-RpS6 (Figure 3D) and phospho:total (Figure 3F) were 
decreased with CR.   
Discussion 
 
We hypothesized that CR does not increase protein synthesis in all protein fractions and 
tissues because of the energy requirements of mRNA translation.  Further, we hypothesized 
that if a nutrient sensitive tissue did increase protein synthesis it would occur in the context of an 
increased anabolic effect to an acute feeding. Our main findings were that CR did not increase 
rates of mixed protein synthesis in response to an acute feeding or over the long term.  
Moreover, short-term responses indicate a potential decrease in mitochondrial protein synthesis 
in the liver during CR.   
Short and long-term protein synthesis.   
Prior to investigation, we hypothesized that measurements of increased rates of protein 
synthesis with CR could have been due to an increased anabolic response to a flooding dose of 
essential amino acids. Others have recently adapted the labeled water method to assess short-
term changes in protein synthesis (17, 31, 32), which allowed us to measure changes in protein 
synthesis to an amino acid bolus over a period of 4 hours.  There was no detectable effect of 
feeding in any tissue and this did not differ between lifelong AL and CR groups.  This finding is 
consistent with what others have found in heart (17, 38).  In liver, however, rates of protein 
synthesis seem to differ based on the amino acid quantity infused (38) indicating a threshold of 





which is contrary to what others have previously reported (17).  There are two potential reasons 
for the lack of a feeding response in the skeletal muscle.  First, the mode of “feeding” is different 
among comparable experiments.  In the current study an oral gavage with an amino acid 
solution was used for the acute feeding.  In other studies, free access to food over 20 hours 
(17), or intravenous infusion (21, 22, 39) was used.   Although we modeled our feeding dose off 
the flooding dose of Smith et al., (21), it is possible that the mode of delivery and the necessity 
of crossing the gut could change metabolic responses to a given comparable amino acid dose.  
Second, in our hands, the incorporation of label over the 4-hour period into skeletal muscle was 
very low due to the slower rate (as compared to liver and heart) of protein synthesis in skeletal 
muscle thus increasing variability around a limit of detection.  Therefore the number of samples 
that we could obtain usable data for were low.  In the future, studies using the acute 
assessment techniques should be undertaken for longer periods of time (5 hours or more) to 
assess skeletal muscle protein synthesis.   
The ability to measure long-term protein synthesis (e.g. days to weeks) is a particular 
advantage of the labeled water approach. Here we report that over the long-term there was no 
effect of CR on mixed protein synthesis in three different tissues.  Long-term synthesis rates 
were greatest in liver, in which protein was already replaced within the 6-week period, followed 
by heart and skeletal muscle.  Previously we assessed the synthesis rates of just the 
mitochondrial protein fraction (mitochondrial biogenesis) over the long-term in liver, heart, and 
skeletal muscle (40).  In that report, liver mitochondrial proteins were 100% new, making these 
data uninterpretable kinetically, with slower rates of synthesis for heart and skeletal muscle.  
The relative synthesis rates between tissues in both the current and our previous publication are 
consistent with those published in neonatal pigs (38).  In the current study we assessed short-
term mitochondrial protein synthesis and found slower rates of synthesis in CR compared to AL 
mice. This finding substantiates that there may be decreased mitochondrial protein synthesis 





previously published report (40) illustrate the importance of assessing multiple tissues when 
exploring the systemic effects of CR since responses seem to vary by tissue.     
 
Methodological considerations   
Recently we proposed that the assessment of rates of protein synthesis is important 
when determining age-related changes (18). It is therefore important to discuss how well our 
short-term and long-term labeled water methods qualitatively and quantitatively support each 
other.  With our short-term measurement liver protein synthesis was greater than heart protein 
synthesis, which was greater than skeletal muscle.  Qualitatively, these rates are supported by 
our long-term outcomes and are in line with what we expect for synthetic rates relative to each 
other in these tissues (38).  Quantitatively, the results of short-term and long-term studies do not 
necessarily match.  As an example, we can use data from short-term and long-term skeletal 
muscle proteins.  Long-term measurements calculate to 0.055%/hr while short-term 
measurements average 0.28%/hr.  It is therefore apparent that values measured over 4 hours 
do not quantitatively predict the long-term values.  It is worth noting that values calculated from 
the long-term experiment are reflective of what others have found with short-term incorporation 
of labeled amino acids (33, 41, 42).  Further, when others (32) simultaneously measured protein 
synthesis with a radioactive phenylalanine tracer and 2H2O methods similar to ours, they also 
found that there were quantitative differences between the methods, but not qualitative 
differences.   
The differences between short and long-term measurements could be explained by 
differences in turnover between the protein pools of the tissue.  It could be that one pool, 
representing 75% of the proteins, is rapidly turned over.  In the current study the short-term 
value of 0.28 %/hr would equate to 100% new protein in approximately 14 days.  A second pool 
representing 25% of the proteins could be synthesized more slowly with minimal turnover in 6 





second pool’s synthesis is minimal, a 6-week integrated value could equate to 0.055 %/hr for 
the entire period.   
Finally, the observation of higher synthesis rates over the short-term is not unique to 
labeled water and may be a result of flooding doses in general.  In rats given a flooding dose of 
[13C6]phenylalanine, skeletal muscle mitochondrial protein synthesis was about 0.6 %/hr (43) a 
value even higher than our values.  Other studies have found similar values in rat mixed muscle 
(32, 44, 45) and all have used some form of a flooding dose.  It has been well documented that 
in skeletal muscle the flooding dose of amino acid was likely causing a feeding response (21, 
22).  However, that should not be the case when using 2H2O (31). Future studies would need to 
consider multiple time points or further tissue fractionation to determine whether this is true.  
This variation of synthesis rates over time reiterates the importance of both short-term and long-
term measurements of protein turnover when investigating CR or other anti-aging interventions.  
 
Translation regulation of protein synthesis.   
In our previous publication using long-term CR mice we reported a general suppression 
of mTOR signaling in CR animals (40). We confirm that finding in the present study since, 
although tissue specific, there is a general decrease in 4E-BP-1 and rpS6 phosphorylation.   In 
this report, as well as our previous, we chose to present phospho, total, and phospho:total ratios 
since it is unclear which is the driving factor in the degree of mTOR activation.  For example, in 
liver, there is a decrease in 4E-BP-1 phosphorylation and no change in total 4E-BP-1 resulting 
in a decreased phospho:total ratio.  However, in RpS6, there is a decrease in phosphorylation 
and a concomitant decrease in total protein resulting in no change in the ratio.  We are unsure 
whether the phosphorylation or the ratio of phosphorylated to total ultimately dictates mTOR 
regulation.  However, responses in liver and heart are consistent with decreased activation of 
the mTOR pathway since any changes are consistently in the direction of decreased activation.  





with a stress response in which energetic constraints, either total energy or energy flux, leads to 
decreased translation initiation (46, 47).  It is therefore interesting that protein synthesis rates 
are maintained in these tissues despite the energetic constraints.  In our previous report (40) we 
demonstrated that cellular proliferation in the liver and heart of CR mice were decreased during 
lifelong CR.  It is therefore apparent that in times of energetic constraints, there are tradeoffs 
between energy consuming cellular processes such as protein synthesis and cellular 
proliferation (as measured by DNA synthesis on our series of studies).  
 
Perspectives and conclusions  
The current report along with our previous report (40) collectively illustrate the 
antagonistic pleiotropy between growth and somatic maintenance (2).  At the center of these 
decisions is the mTOR pathway due to its role in cell growth and survival.  In skeletal muscle 
strategies such as amino acid feeding serve to increase protein synthesis by activation of the 
mTOR pathway (48) and have been strongly advocated for an older population to stimulate 
growth and slow sarcopenia.  However, suppressed mTOR signaling seems to be a common 
feature of longevity models (49), and chronic rapamycin feeding, which inhibits mTOR signaling, 
decrease cellular proliferation (40) and increase longevity (50). Because of differences between 
a cells propensity to replicate, it is likely that tissue specific responses to energetic constraints 
or other cellular stresses will play a large role in determining the success of anti-aging 
treatments.  We therefore suggest approaches that consider multiple tissues for systemic anti-
aging treatments. 
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Figure A.2.  Rates of protein synthesis assessed over the short term (4 hours) (A and B) and 
long term (6 weeks) in liver, heart, and skeletal muscle of lifelong CR or AL male B6D2F1 mice.  
Acute feeding of an amino acid solution did not increase mixed protein synthesis in any tissue 
and responses did not differ between AL and CR mice (A).  Because no differences were noted 
with feeding, Fed and Fasted groups were collapsed into one group and compared (panel 
insets).  Acute feeding did not increase mitochondrial protein synthesis (B), but the liver of CR 
mice had decreased rates of mitochondrial protein synthesis compared with AL mice in the 
fasted and fed conditions (B). Again, the only difference was slower rates of mitochondrial 
protein synthesis in the liver of CR animals.  When animals were compared over the long term, 
there were no differences in mixed protein synthesis, although the liver protein was 100% 
replaced by this time point and therefore cannot be interpreted kinetically.  FSR = fractional 
synthesis rate.  *Significantly different from AL, p<.05. Mice were purchased at 6, 12, and 21 
months of age into both AL and CR groups and were studies as one group.  For short-term 
study, n = 15-17 for heart and liver (both fractions), 9-13 for skeletal muscle mixed, and 2-5 for 







Figure A.3.  4E-BP-1, phospho-4E-BP-1[Thr37/46], RpS6, and phospho-RpS6 [Ser240/244] 
were determined by Western blot for phospho (A and D), total (B and E), and phospho:total (C 
and F) in liver, heart, and skeletal muscle of AL and CR mice in the fasted and fed conditions.  
*Significantly different from AL, p < .05.  #Significantly different from Fasted, p < .05. n = 7-10 


















Slowing the aging process can reduce the risk for multiple chronic diseases 
simultaneously.  It is increasingly recognized that maintaining protein homeostasis (or 
proteostasis) is important for slowing the aging process. Since proteostasis is multi-faceted, 
assessing it is not a simple task and requires use of methods capable of capturing dynamic 
information. This review will introduce the concept of proteostasis, how to assess protein and 
DNA synthesis using deuterium oxide (D2O), and how protein and DNA synthesis outcomes 
provide insight into proteostatic mechanisms.  Finally, we provide a discussion on how these 
assessments of protein and DNA synthesis are “mechanistic” investigations and provide an 
appropriate framework for the further development of slowed-aging treatments.   
Introduction 
 
Long-lived models are ideal for studying slowed aging because slowed aging, in the 
absence of trauma or infectious disease, is presumably what imparts long life.  Two potential 
approaches for studying slowed aging are to examine unique characteristics or manipulations 
that lead to slowed aging in a given model, or to examine shared characteristics of a variety of 
long-lived models.  This mini-review will present a strategy for the latter, because we believe 
that shared characteristics are potentially more meaningful than unique characteristics when 
developing strategies for slowing the aging process.   
Protein homeostasis (i.e. proteostasis) refers to controlling the concentration, location, 
and conformation of proteins in cells (Balch et al., 2008).  In addition to protein folding, 





“proteostasis regulators” that can restore protein homeostasis (Balch et al., 2008).  The ability to 
maintain proteostasis has become a key outcome in aging research (Austad, 2010; Balch et al., 
2008; Perez et al., 2009; Salmon et al., 2009).  One characteristic of slowed aging is the ability 
to maintain healthy, functional proteins (proteostasis) since proteins play an important role in 
cellular stability and repair (Treaster et al., 2013).  Whether or not increased proteostasis is an 
underlying mechanism of slowed aging is yet to be definitively determined, but investigations 
into proteostasis provide a reasonable contextual framework for studying the aging process.  Of 
course if one wants to study proteostasis, appropriate methods to do so are necessary.  Since 
proteostasis is a dynamic process, capturing the process is not a simple task.  In this review, we 
will present one strategy for the assessment of proteostasis and suggest reasons why this 
approach provides valuable insight into the aging process and how to slow its progression. 
Discussion 
 
Distinguishing cell growth, adaptation and repair to understand proteostasis 
When a proliferative cell replicates it doubles its mass to have two equal sized daughter 
cells (Grebien et al., 2005). When a post-mitotic cell, such as a skeletal muscle cell, 
hypertrophies it recruits DNA from resident stem cells (Collins et al., 2005) to maintain a 
constant DNA to cytoplasm ratio (Allen et al., 1999; Pavlath et al., 1989). Therefore, in both 
proliferative and post-mitotic cells, new DNA, either from true DNA replication or DNA 
recruitment, is associated with increases in protein synthesis.  
The capacity for cells to enzymatically repair proteins is low (Mary et al., 2004; 
Mortimore and Pösö, 1987; Poppek and Grune, 2005).  Therefore to maintain proteostasis, 
damaged proteins are removed and replaced with new proteins (Poppek and Grune, 2005).  To 
cope with environmental stresses, cells constantly integrate multiple signals that relay 
information about the intra- and extracellular environments and synthesize new proteins to 





adapt to the environment maintains cellular protein homeostasis. These processes are counter 
to the previously described phenomenon in which protein synthesis increases in parallel with an 
increase in cell proliferation.  In one case, there are adaptive responses to prevent or replace 
protein damage to maintain proteostasis, whereas in the other, protein synthesis increases to 
equip the newly made cells.  By this rationale, when examining protein synthesis in the context 
of increasing proteostatic mechanisms, one should consider both the rate of protein synthesis 
and the rate of cellular proliferation in order to account for how much protein is directed toward 
cell doubling versus how much is directed toward maintaining existing cellular structures. 
 
Using D2O for assessing synthesis of DNA and protein 
Here we propose the novel idea that when measuring protein synthesis as a proteostatic 
mechanism, it is also necessary to consider cell proliferation.  The assessments of rates of 
synthesis are especially important in this context.  During periods of cellular stress, there are 
several post-transcriptional mechanisms such as selective translation (Zid et al., 2009), stress 
granules (Kimball et al., 2003), and micro-RNA (Adeli, 2011), that determine which mRNAs are 
translated to protein.  Therefore, measurements of cellular signaling and mRNA content are not 
appropriate for assessing protein synthesis because they fail to account for post-transcriptional 
mechanisms, a concept we have previously discussed (Miller and Hamilton, 2012).  Assessing 
rates of synthesis of new protein and DNA is critical because simply measuring content or 
number masks ongoing cellular processes.  For example, if protein synthesis increased by one 
hundred-fold and was matched by a one hundred-fold increase in breakdown, there would be no 
detectable change in protein content even though there were positive outcomes related to 
proteostasis.  
The use of deuterium oxide (D2O) in vivo allows for the simultaneous measurement of 
both protein (Busch et al., 2006; Drake et al., 2013; Miller et al., 2012; 2013; Robinson et al., 





Robinson et al., 2011).  To perform a study, D2O is introduced as an intraperitoneal injection 
(Gasier et al., 2009; Miller et al., 2013; Yuan et al., 2008) or as drinking water (Drake et al., 
2013; Miller et al., 2013; 2012) to enrich the body water pool with deuterium (Figure 1).  
Equilibrium is rapidly established between the body water deuterium enrichment and the 
enrichment of metabolites that contain labile hydrogens.  Those labeled metabolites (the 
precursors) are then incorporated into synthetic products (ex. deoxyribose of DNA and alanine 
within proteins) and can then be used to calculate synthesis rates by standard precursor/product 
calculations (Figure 1).  A particular advantage of using D2O, compared to traditional 
approaches, is that it can be used over prolonged periods to capture the synthesis of slowly 
synthesized species while an organism is free living.  This ability to measure outcomes over the 
long-term is advantageous because the sum of physiological effects over time, not just short 
snapshots that vary based on the prevailing metabolic state, are assessed.  When studying 
processes associated with aging and slowed aging in laboratory models and humans, the ability 
to capture data during prolonged free living removes uncertainty associated with more 
traditional isotope approaches reflective of only a 4-6 hour time frame.   
 
What measuring proteostasis tells us about slowed aging 
Long-lived models (i.e. models of slowed aging) are ideally suited for use in studies to 
identify the mechanisms responsible for aging and age-related declines.  Calorically restricted 
(CR) (Masoro, 2005) and rapamycin treated mice (Wilkinson et al., 2012) are long-lived and 
demonstrate characteristics consistent with prolonged healthspan.  These models also share 
the characteristic of decreased mechanistic (formerly mammalian) target of rapamycin (mTOR) 
activity (Drake et al., 2013; Harrison et al., 2009; Miller et al., 2012), a key modulator of protein 
synthesis and cell cycling (Sengupta et al., 2010).  However, as discussed below, decreased 






Caloric restriction - Our first investigation into proteostasis began with CR mice because of the 
abundance of studies investigating longevity in this model.  We were particularly interested in 
this model because some evidence suggests that mitochondrial biogenesis is maintained or 
increased during CR (Nisoli, 2005), while others have questioned whether CR increases 
mitochondrial biogenesis (Hancock et al., 2011).  There had also been speculation that 
decreased protein synthesis is a key mechanism leading to lifespan extension (Kapahi, 2010; 
Tavernarakis, 2008).  Given the background provided above regarding post-transcriptional 
mechanisms, especially those employed during activation of pathways associated with 
energetic stress, we thought that it was possible that protein synthetic responses were not being 
truly captured with the methods previously employed.  Using D2O we measured protein 
synthesis, including mitochondrial protein synthesis, both acutely (4 hours) and over the long-
term (6 weeks) in liver, heart, and skeletal muscle of CR animals compared to ad libitum fed 
controls (Miller et al., 2013; 2012).  We found that almost uniformly among the three tissues, 
protein synthesis was maintained in CR mice, including in the mitochondrial fraction (Miller et 
al., 2013; 2012) (data from skeletal muscle show in Figure 2A).  Although the finding that there 
is no difference in protein synthesis between CR and controls (CON) initially appears fairly 
unremarkable, when considered in relation to DNA synthesis, a different picture emerges 
(Figure 2B).  Because DNA synthesis rates were lower in CR animals compared to CON, the 
ratio of protein synthesis to DNA synthesis is greater in CR compared to CON.  Therefore, it 
appears that a greater proportion of protein synthesis is dedicated to proteostasis rather than 
cell proliferation.  That the CR mice maintained rates of protein synthesis is counter to the idea 
that a decrease in protein synthesis is a mechanism of slowed aging.  However, by also 
measuring DNA synthesis, we found that maintenance of protein synthetic rates happened in 
the face of decreased DNA synthesis, indicating that an increase in proteostatic mechanisms is 






Rapamycin treatment - Inhibition of mTOR increases lifespan in a variety of non-mammalian 
species (Jia et al., 2004; Kapahi et al., 2010; Powers et al., 2006) while chronic administration of 
the mTOR inhibitor rapamycin has been shown to extend mean and maximal life span in 
heterogeneous mice (Harrison et al., 2009).  Given that rapamycin inhibits mTOR, it was 
surprising to us that no one had previously measured protein synthesis and cell replication in 
long-lived rapamycin treated mice.  In our study, we measured protein synthesis and DNA 
synthesis over a 4-week period in heterogeneous mice treated for 12 weeks with rapamycin 
(Drake et al., 2013).  In heart tissue we found no differences between rapamycin treated mice 
(Rap) or controls (CON) for protein synthesis rates of mixed, cytosolic, or mitochondrial proteins 
(Drake et al., 2013) (Figure 2C).  However, in the heart (as well as skeletal muscle), there was 
a decrease in DNA synthesis so that when the protein synthesis to DNA synthesis ratio was 
calculated, it became apparent that like CR, there is an increase in proteostatic mechanisms in 
Rap mice compared to CON (Fig. 2D).  
 
Crowded litter - The crowded litter model (CL) is a relatively newly described long-lived model 
(Steinbaugh et al., 2012; Sun et al., 2009).  The model is an extension of the developmental 
origins of health and disease hypothesis (Hales and Barker, 2001) in that the critical 
developmental period spans beyond the in utero environment to the immediate post-natal 
environment.  In the CL model, litter size is increased by 50% and this increase in litter size 
presumably imposes a transient caloric restriction period until the pups are weaned and 
subsequently given free access to food.  Even though the CL mice are given ad libitum access 
to food for the remainder of their lives, mean and maximal lifespan are increased (Sun et al., 
2009).   
Recently, we characterized protein and DNA synthetic rates in long-lived CL mice and 
our findings took us quite by surprise (Drake et al., 2014).  We found that compared to normal 





liver, and skeletal muscle in all sub-fractions examined (Drake et al., 2014) (skeletal muscle 
shown in Fig. 2E).   In addition, as opposed to previously examined long-lived models, DNA 
synthesis was relatively unchanged in the same tissues examined in CR and rapamycin models.  
Although synthesis rates were seemingly divergent from previously explored long-lived models, 
when the protein synthesis to DNA synthesis ratio was calculated, it again appeared that there 
was greater activation of proteostatic mechanisms in the CL mice compared to CON (skeletal 
muscle shown in Fig. 2F).  Finally, activation of ribosomal protein subunit S6 (rpS6), a marker of 
mTOR activation, was greater in CL compared to CON (Drake et al., 2014).  Therefore, 
although a decrease in mTOR activity is thought to be important for lifespan extension, and is 
indeed decreased in both the CR and Rap mice, the CL model illustrates that the resultant 
improvement in proteostasis is likely a more important outcome than decreased mTOR activity 
itself.   
 
Why are studies of proteostasis mechanistic?  
It is easy to dismiss the measurement of protein and DNA synthesis as largely 
descriptive and not mechanistic.  However, when investigating the end result of cellular 
processes, the measurement of synthesis rates is perhaps one of the more insightful 
mechanistic outcomes.  For example, aerobic exercise, a known modulator of the aging process 
(Short et al., 2005), activates both the transcriptional coactivator peroxisome proliferator-
activated receptor-coactivator-1α (PGC-1α) (Pilegaard et al., 2003) and AMP-activated protein 
kinase (AMPK) (Winder and Hardie, 1996).  Whereas PGC-1α activation triggers increases in 
the transcription of nuclear and mitochondrial coded mRNA for mitochondrial protein synthesis, 
AMPK inhibits protein translation through its interactions with mTOR (Mounier et al., 2011).  
Therefore, without a measurement of protein synthesis, it is difficult to determine whether the 
newly transcribed mRNA was actually translated into new protein.  Many models of lifespan 





gene targets can have multiple downstream effects (pleiotropy), many of which are 
unanticipated or uninvestigated, the synthetic outcomes actually provide exceptional insight into 
why and how changes in lifespan occur.  The present review proposes that considering protein 
synthesis rates in the context of DNA synthesis rates provides novel insight into proteostatic 
mechanisms or outcomes.  These measurements are perhaps even more discerning when 
using in vivo models of slowed aging since long-lived models have complex systemic changes 
that might not be captured during analysis of signaling pathways or protein contents selected a 
priori.  
To date, our assessments strongly support the concept that slowed aging is associated 
with improved proteostasis.  Importantly, they also illustrate the importance of using the 
assessment of synthetic rates as a mechanistic outcome.  The inhibition of mTOR has been the 
focus of much research, and rightly so, because of its potential to slow the aging process (Flynn 
et al., 2013; Wilkinson et al., 2012; Wu et al., 2013; Ye et al., 2013).  However, our findings in 
the CL slowed aging model indicate that lifespan extension can happen independently of a 
decrease in mTOR activity (Drake et al., 2014).  This lifespan extension independent of a 
decrease in mTOR activity is seen in other longevity treatments such as branched chain amino 
acid supplementation (D'Antona et al., 2010).  Therefore, future studies could be enhanced by 
focusing on proteostasis as a key regulator, or mechanism, of lifespan extension.   
 
Conclusions 
 By recognizing that proteostasis is a key feature of slowed aging, promotion of 
proteostatic mechanisms can then be a mechanistic target to slow the aging process.  In 
addition to protein folding, trafficking, and degradation, a change in protein synthesis is 
considered one of the primary “proteostasis regulators” that can restore protein homeostasis 
and is thus a potential target for slowed aging treatments.  The assessment of protein synthesis 





transcriptional processes.  However, to properly assess the increase in protein synthesis to 
proteostasis, one must also consider the making of new cells to determine how much protein 
synthesis is dedicated to new cells versus replacing of existing proteins.  It is our goal to further 
characterize protein synthetic responses in long-lived models in order to improve proteostasis to 







Figure A.4. Using D2O for assessing synthesis of DNA and protein. Following an intraperitoneal 
injection, D2O (2H2O) is administered via the animal’s drinking water where it equilibrates with 
the body water pool (A).  Deuterium in the body water pool exchanges with labile hydrogen in 
metabolites that are incorporated into synthetic products (B).  For example, deuterium is 
incorporated into the deoxyribose of DNA and the amino acid alanine, which are then 
incorporated into DNA and protein, respectively (B).  DNA and protein synthesis can be 
simultaneously assessed across multiple tissues, such as skeletal muscle, heart, and liver as 








Figure A.5.  Representative protein synthesis, DNA synthesis and protein synthesis:DNA 
synthesis in three models of slowed aging.  A) Synthetic rates of DNA and three fraction of 
skeletal muscle (Mixed = myofibrillar, CYTO = cytoplasmic, MITO = Mitochondrial) in lifelong 
calorically restricted mice (CR) and ad lib fed controls (AL).  Although there is a trend for greater 
mitochondrial protein synthesis in CR, protein synthesis rates are largely similar between CR 
and AL (data reproduced from (Miller et al., 2013; 2012)).  B) When the data from skeletal 
muscle are expressed as a synthesis ratio, it is clear that there is increase protein synthesis 
dedicated to proteostasis in CR animals as compared to AL.  C) Synthetic rates of DNA and 
three fraction of heart in mice chronically fed rapamycin (RAP) and age matched controls 
(CON).  There are no differences between RAP and CON for protein synthetic rates, although 





synthesis ratio, there is increase protein synthesis dedicated to proteostasis in RAP compared 
to CON (data reproduced from (Drake et al., 2013)).  E) Synthetic rates of DNA and three 
fractions of skeletal muscle in crowded litter mice (CL) and normal litter sized controls (CON).  
As opposed to CR and RAP models, there is greater protein synthesis CL compared to CON 
and no difference in DNA synthesis (data reproduced from Drake et al., 2014)).    F) Despite 
qualitative differences in synthesis rates between CL compared to CR and RAP, the ratio of 
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